<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucsf_postprints/rss"/>
    <ttl>720</ttl>
    <title>Recent ucsf_postprints items</title>
    <link>https://escholarship.org/uc/ucsf_postprints/rss</link>
    <description>Recent eScholarship items from UC San Francisco Previously Published Works</description>
    <pubDate>Fri, 15 May 2026 07:22:35 +0000</pubDate>
    <item>
      <title>Evidence Over Eminence: Rethinking Specialty Guidelines Amid the ATS-IDSA Debate</title>
      <link>https://escholarship.org/uc/item/8ws6t9dn</link>
      <description>Evidence Over Eminence: Rethinking Specialty Guidelines Amid the ATS-IDSA Debate</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8ws6t9dn</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Spellberg, Brad</name>
      </author>
      <author>
        <name>Ghanem, Bassam</name>
      </author>
      <author>
        <name>Morante-Ruiz, Miguel</name>
      </author>
      <author>
        <name>Bortolussi-Courval, Émilie</name>
      </author>
      <author>
        <name>Makam, Anil N</name>
        <uri>https://orcid.org/0000-0001-7072-9946</uri>
      </author>
      <author>
        <name>Ergenc, Zeynep</name>
      </author>
      <author>
        <name>Riccardi, Niccolo'</name>
      </author>
      <author>
        <name>Meyer-Sautter, Pascal</name>
      </author>
      <author>
        <name>Alharbi, Saad</name>
      </author>
      <author>
        <name>Rocha-Pereira, Nuno</name>
      </author>
      <author>
        <name>Centor, Robert M</name>
      </author>
      <author>
        <name>Ryder, Jonathan</name>
      </author>
      <author>
        <name>Bhoojhawon, Guru</name>
      </author>
      <author>
        <name>Ahmed, Ihab</name>
      </author>
      <author>
        <name>Cabanilla, M Gabriela</name>
      </author>
      <author>
        <name>Almeida, Francisco</name>
      </author>
      <author>
        <name>Pimentel, Bernardo Vidal</name>
      </author>
      <author>
        <name>Starkey, Jeffrey</name>
      </author>
      <author>
        <name>Costa, Rodrigo PL</name>
      </author>
      <author>
        <name>Maraolo, Alberto Enrico</name>
      </author>
      <author>
        <name>Tong, Steven YC</name>
      </author>
      <author>
        <name>Anderson, Daniel T</name>
      </author>
      <author>
        <name>Murri, Rita</name>
      </author>
      <author>
        <name>McDonald, Emily G</name>
      </author>
      <author>
        <name>Lee, Todd C</name>
      </author>
    </item>
    <item>
      <title>The phage nucleus synergizes with an anti-defense protein to resist bacterial immunity</title>
      <link>https://escholarship.org/uc/item/0qp9m9t3</link>
      <description>Chimallivirus bacteriophages enclose their replicating genomes in a protein-based compartment termed the phage nucleus. While the phage nucleus segregates phage DNA from host immune proteins, it is not known if additional factors are required to protect against DNA-targeting host defenses. Here, we identify a chimallivirus-encoded DarG2-like antitoxin that localizes to the phage nucleus and provides protection against phage-targeting DarTG2 toxin-antitoxin systems. This protein, which we term AdfM (anti-darT factor macro), contains a macrodomain and removes DarT2-mediated ADP-ribose modifications from DNA. In the absence of AdfM, DarT2 modifies phage DNA and restricts chimallivirus replication despite being largely excluded from the phage nucleus. Increasing the nuclear concentration of DarT2 while decreasing the nuclear concentration of AdfM reduces phage replication. These results show that the phage nucleus is insufficient to completely protect the chimallivirus genome from...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0qp9m9t3</guid>
      <pubDate>Wed, 13 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Morgan, Chase J</name>
      </author>
      <author>
        <name>Rani, Phoolwanti</name>
      </author>
      <author>
        <name>Deep, Amar</name>
      </author>
      <author>
        <name>Liu, Rui</name>
      </author>
      <author>
        <name>Basu, Dwaipayan</name>
      </author>
      <author>
        <name>Chambers, Lydia R</name>
      </author>
      <author>
        <name>Li, Ying-Xing</name>
      </author>
      <author>
        <name>Levine, Makaela</name>
      </author>
      <author>
        <name>Hsieh, Kendall</name>
      </author>
      <author>
        <name>Adler, Benjamin A</name>
      </author>
      <author>
        <name>Birkholz, Erica</name>
      </author>
      <author>
        <name>Doudna, Jennifer A</name>
      </author>
      <author>
        <name>Villa, Elizabeth</name>
        <uri>https://orcid.org/0000-0003-4677-9809</uri>
      </author>
      <author>
        <name>Corbett, Kevin D</name>
        <uri>https://orcid.org/0000-0001-5854-2388</uri>
      </author>
      <author>
        <name>Pogliano, Joe</name>
      </author>
    </item>
    <item>
      <title>Neuroeconomic Measures of Impaired Decision-Making in Frontotemporal Dementia (S18.001)</title>
      <link>https://escholarship.org/uc/item/94d6d78w</link>
      <description>Neuroeconomic Measures of Impaired Decision-Making in Frontotemporal Dementia (S18.001)</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/94d6d78w</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chiong, Winston</name>
        <uri>https://orcid.org/0000-0001-9188-1920</uri>
      </author>
      <author>
        <name>Wood, Kristie</name>
      </author>
      <author>
        <name>Kayser, Andrew</name>
      </author>
      <author>
        <name>D'Esposito, Mark</name>
      </author>
      <author>
        <name>Rosen, Howard</name>
      </author>
      <author>
        <name>Miller, Bruce</name>
      </author>
      <author>
        <name>Kramer, Joel</name>
      </author>
    </item>
    <item>
      <title>Testing the Presumption of Consent to Emergency Thrombolysis for Stroke (S35.005)</title>
      <link>https://escholarship.org/uc/item/3xz0s98z</link>
      <description>Testing the Presumption of Consent to Emergency Thrombolysis for Stroke (S35.005)</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3xz0s98z</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chiong, Winston</name>
        <uri>https://orcid.org/0000-0001-9188-1920</uri>
      </author>
      <author>
        <name>Kim, Anthony</name>
        <uri>https://orcid.org/0000-0002-8095-6517</uri>
      </author>
      <author>
        <name>Huang, Ivy</name>
      </author>
      <author>
        <name>Farahany, Nita</name>
      </author>
      <author>
        <name>Josephson, S</name>
      </author>
    </item>
    <item>
      <title>Equity-enhanced glaucoma progression prediction from OCT with knowledge distillation</title>
      <link>https://escholarship.org/uc/item/1rk657kc</link>
      <description>Glaucoma is a progressive disease that can lead to permanent vision loss, making progression prediction vital for guiding effective treatment. Deep learning aids progression prediction but may yield unequal outcomes across demographic groups. We proposed a model called FairDist, which utilized baseline optical coherence tomography scans to predict glaucoma progression. An equity-aware EfficientNet was trained for glaucoma detection, which was then adapted for progression prediction with knowledge distillation. Model accuracy was measured by the AUC, Sensitivity, Specificity, and equity was assessed using equity-scaled AUC, which adjusts AUC by accounting for subgroup disparities. The mean deviation, fast progression, and total deviation pointwise progression were explored in this work. For both progression types, FairDist achieved the highest AUC and equity-scaled AUC for gender and racial groups, compared to methods with and without unfairness mitigation strategies. FairDist...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rk657kc</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Afolabi, Sulaiman O</name>
      </author>
      <author>
        <name>Gheisi, Leila</name>
      </author>
      <author>
        <name>Shan, Jing</name>
      </author>
      <author>
        <name>Shen, Lucy Q</name>
      </author>
      <author>
        <name>Wang, Mengyu</name>
      </author>
      <author>
        <name>Shi, Min</name>
      </author>
    </item>
    <item>
      <title>Changing Trends in Glaucoma Surgery Over the Past 5 Years in China</title>
      <link>https://escholarship.org/uc/item/1m92s93q</link>
      <description>PURPOSE: To analyze the trends of glaucoma surgery procedures over the past 5 years among hospitals across major provinces in China.
MATERIALS AND METHODS: This was a retrospective observational study based on medical records. We obtained the annual numbers of commonly performed glaucoma incisional surgeries from 57 hospitals of 30 provincial regions in the Chinese Glaucoma Study Consortium (CGSC) from January 2015 to September 2019. The trend of glaucoma surgery was analyzed by Cochrane-Armitage trend test.
RESULTS: Trabeculectomy, cataract extraction combined with goniosynechialysis, cataract extraction combined with trabeculectomy, and surgical peripheral iridotomy (SPI) were the top 4 surgical procedures percentages of which have the most substantial change over the course of 2015 to 2019 (all Ptrend &amp;lt;0.001). Numbers of trabeculectomies decreased significantly from 47.59% in 2015 to 31.21% in 2019; cataract extraction combined with goniosynechialysis increased from 12.12%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1m92s93q</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Qiao, Chunyan</name>
      </author>
      <author>
        <name>Zhang, Hui</name>
      </author>
      <author>
        <name>Cao, Kai</name>
      </author>
      <author>
        <name>Tian, Jiaxin</name>
      </author>
      <author>
        <name>Chung, Tham Yih</name>
      </author>
      <author>
        <name>Shan, Jing</name>
        <uri>https://orcid.org/0000-0003-0590-9937</uri>
      </author>
      <author>
        <name>Han, Ying</name>
      </author>
      <author>
        <name>Wang, Ningli</name>
      </author>
      <author>
        <name>Consortium, on Behalf of the Investigators for the Chinese Glaucoma Study</name>
      </author>
    </item>
    <item>
      <title>Multi-Dataset Comparison of Vision Transformers and Convolutional Neural Networks for Detecting Glaucomatous Optic Neuropathy from Fundus Photographs</title>
      <link>https://escholarship.org/uc/item/1jq2q421</link>
      <description>Glaucomatous optic neuropathy (GON) can be diagnosed and monitored using fundus photography, a widely available and low-cost approach already adopted for automated screening of ophthalmic diseases such as diabetic retinopathy. Despite this, the lack of validated early screening approaches remains a major obstacle in the prevention of glaucoma-related blindness. Deep learning models have gained significant interest as potential solutions, as these models offer objective and high-throughput methods for processing image-based medical data. While convolutional neural networks (CNN) have been widely utilized for these purposes, more recent advances in the application of Transformer architectures have led to new models, including Vision Transformer (ViT,) that have shown promise in many domains of image analysis. However, previous comparisons of these two architectures have not sufficiently compared models side-by-side with more than a single dataset, making it unclear which model is...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1jq2q421</guid>
      <pubDate>Tue, 12 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Hwang, Elizabeth E</name>
      </author>
      <author>
        <name>Chen, Dake</name>
      </author>
      <author>
        <name>Han, Ying</name>
      </author>
      <author>
        <name>Jia, Lin</name>
      </author>
      <author>
        <name>Shan, Jing</name>
        <uri>https://orcid.org/0000-0003-0590-9937</uri>
      </author>
    </item>
    <item>
      <title>Cost-effectiveness of a pictorial medication sheet for older adults with heart failure and cognitive impairment</title>
      <link>https://escholarship.org/uc/item/57x0r08h</link>
      <description>BackgroundOlder adults with chronic health conditions like heart failure (HF) and cognitive impairment face challenges managing complex medication regimens, leading to poor adherence, worsening clinical status, and increased healthcare costs. Many existing interventions to improve medication adherence depend on digital technologies that may be too complex or require consistent caregiver support limiting their effectiveness in this population. Prior research demonstrated the efficacy of a simple pictorial medication sheet intervention compared to usual care. This study evaluates the cost-effectiveness of a pictorial medication sheet compared to usual care for older adults with HF and cognitive impairment.MethodsWe developed a decision tree model with disease states in Microsoft Excel to evaluate changes in costs and quality-adjusted life years (QALYs) after implementing the intervention for older adults living with cognitive impairment and HF. The base case model used a one-year...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/57x0r08h</guid>
      <pubDate>Mon, 11 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Vannoy, Kaylee B</name>
      </author>
      <author>
        <name>Hawkins, Lee Ann</name>
      </author>
      <author>
        <name>Kahn, James G</name>
      </author>
    </item>
    <item>
      <title>MENOPAUSE IS ASSOCIATED WITH LOWER LUNG FUNCTION IN WOMEN WITH AND WITHOUT HIV</title>
      <link>https://escholarship.org/uc/item/7m59w722</link>
      <description>BACKGROUND: Menopause accelerates lung function decline in women without HIV, but whether menopause modifies lung function in women with HIV (WWH) is unknown.
RESEARCH QUESTION: Is menopause associated with lung function in women with and at-risk for HIV?
STUDY DESIGN AND METHODS: Pulmonary function tests (1116 spirometry, 615 diffusing capacity for carbon monoxide [DLco]) collected from 2018-2019 in 1,206 participants from the Women's Interagency HIV Study were included. In this cross-sectional analysis, women were categorized into groups defined by age (41-50, 51-60) and by menopausal phase as determined by anti-Müllerian hormone, a biomarker of ovarian reserve. Linear regression models determined the differences in mean FEV1, FVC, and DLco by menopausal phase compared to women in the same age group.
RESULTS: Overall, 71% were WWH, 65% were Black, and the median age was 52 years; 36% and 31% reported current and former smoking, respectively, and 30% were premenopausal/early...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7m59w722</guid>
      <pubDate>Fri, 8 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Abelman, Rebecca A</name>
      </author>
      <author>
        <name>Xia, Fan</name>
      </author>
      <author>
        <name>Drummond, M Bradley</name>
      </author>
      <author>
        <name>Kempf, Mirjam-Colette</name>
      </author>
      <author>
        <name>Alcaide, Maria L</name>
      </author>
      <author>
        <name>Collins, Lauren F</name>
      </author>
      <author>
        <name>Spence, Amanda Blair</name>
      </author>
      <author>
        <name>Peters, Brandilyn A</name>
      </author>
      <author>
        <name>Gustafson, Deborah</name>
      </author>
      <author>
        <name>Kunisaki, Ken M</name>
      </author>
      <author>
        <name>Wang, Richard J</name>
      </author>
      <author>
        <name>Tien, Phyllis C</name>
      </author>
      <author>
        <name>Huang, Laurence</name>
        <uri>https://orcid.org/0000-0003-3888-2195</uri>
      </author>
    </item>
    <item>
      <title>Spatial coupling of enlarged perivascular spaces and white matter lesions across the Alzheimer's disease continuum</title>
      <link>https://escholarship.org/uc/item/3pq3s1gk</link>
      <description>Introduction: Emerging evidence suggests that impaired waste-clearance systems contribute to Alzheimer's disease pathogenesis, yet the etiology of clearance dysfunction markers, such as enlarged perivascular spaces, remains unclear. Because enlarged perivascular spaces and white matter lesions are both consequences of microvascular injury involving neuroinflammation and impaired cerebrovascular function, we hypothesize that these markers may be spatially coupled through local interstitial fluid stagnation, where impaired perivascular clearance associates with white matter injury.
Methods: We assessed global perivascular space differences and correlations across diagnostic and biomarker-informed groups in the Alzheimer's Disease Neuroimaging Initiative dataset within whole brain, white matter, and basal ganglia regions, as well as within and outside of white matter lesions. To assess the spatial relationships between enlarged perivascular spaces and white matter lesions, we examined...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3pq3s1gk</guid>
      <pubDate>Fri, 8 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tang, Serena</name>
      </author>
      <author>
        <name>Thropp, Pamela</name>
      </author>
      <author>
        <name>Hausle, Isabella</name>
      </author>
      <author>
        <name>Younes, Kyan</name>
      </author>
      <author>
        <name>Tosun, Duygu</name>
      </author>
    </item>
    <item>
      <title>Bridging community-engaged research and implementation science methods to advance public health practice</title>
      <link>https://escholarship.org/uc/item/9jf1b1m3</link>
      <description>Addressing public health challenges through equitable, evidence-based strategies remains a&amp;nbsp;pressing global need. Implementation science bridges research and practice, offering methods to improve intervention design, delivery, and evaluation. Concurrently, community-engaged research embeds equity and trust into public health initiatives. This paper introduces selected community engagement methods and related implementation science approaches to address characteristic common constraints in public health practice, illustrated with real-world examples. Adapting the Knowledge to Action framework, we present a&amp;nbsp;discussion of community-engaged methods and accompanying case studies. The discussion follows four phases present in applied public health research: (1)&amp;nbsp;identifying and defining the problem, (2)&amp;nbsp;designing and modifying the intervention, (3)&amp;nbsp;evaluating the intervention, and (4)&amp;nbsp;communicating and disseminating findings. For each phase, we highlight...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9jf1b1m3</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Handley, Margaret A</name>
        <uri>https://orcid.org/0000-0001-5034-2111</uri>
      </author>
      <author>
        <name>Abascal Miguel, Lucía</name>
      </author>
      <author>
        <name>Thompson, Lisa Marie</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>Velloza, Jennifer</name>
      </author>
    </item>
    <item>
      <title>Age-dependent reference intervals for cerebrospinal fluid and urine biomarkers of mucopolysaccharidoses</title>
      <link>https://escholarship.org/uc/item/9g9503dq</link>
      <description>Mucopolysaccharidoses (MPSs) are characterized by deficient activity of lysosomal hydrolase enzymes, leading to progressive accumulation of glycosaminoglycans. These glycosaminoglycans can be assayed in biofluids as potential markers of disease severity and response to disease-modifying therapies. This study sought to calculate control reference intervals in a largely pediatric population for key MPS biomarkers: heparan sulfate (HS) and dermatan sulfate (DS) in cerebrospinal fluid (CSF) and urine, and CSF monosialic gangliosides GM2 and GM3. We also explored the effect of age on biomarker levels. Biomarker levels were measured using liquid chromatography-tandem mass spectrometry in CSF and urine samples from pediatric and young adult donors and were compared with baseline CSF and urine biomarker levels from an ongoing Phase 1/2 study of children with MPS II. Age-specific reference intervals were estimated for CSF HS, DS, and GM2, and for urine HS, DS, and the sum of HS and DS,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9g9503dq</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Herber, Candice B</name>
      </author>
      <author>
        <name>Xiao, Shaohua</name>
      </author>
      <author>
        <name>Gho, Deborah S</name>
      </author>
      <author>
        <name>Meyer, Ana-Claire L</name>
      </author>
      <author>
        <name>Tsogtbaatar, Buyankhishig</name>
      </author>
      <author>
        <name>Suh, Jung H</name>
      </author>
      <author>
        <name>Fang, Meng</name>
      </author>
      <author>
        <name>Huntwork-Rodriguez, Sarah</name>
      </author>
      <author>
        <name>Model, Fabian</name>
      </author>
      <author>
        <name>Ireton, Kyle</name>
      </author>
      <author>
        <name>Zhu, Yuda</name>
      </author>
      <author>
        <name>Saba, Julie D</name>
      </author>
      <author>
        <name>White, Kristie L</name>
      </author>
      <author>
        <name>Bhalla, Akhil</name>
      </author>
    </item>
    <item>
      <title>Five strategies for clinicians to advance diagnostic excellence</title>
      <link>https://escholarship.org/uc/item/8s76r9xk</link>
      <description>Five strategies for clinicians to advance diagnostic excellence</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8s76r9xk</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Singh, Hardeep</name>
      </author>
      <author>
        <name>Connor, Denise M</name>
        <uri>https://orcid.org/0000-0001-6281-4438</uri>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
    </item>
    <item>
      <title>Problem representation in the age of artificial intelligence: the state of a dying art?</title>
      <link>https://escholarship.org/uc/item/8dz04621</link>
      <description>Since its introduction into clinical reasoning education, the concept of the problem representation (PR)&amp;nbsp;-&amp;nbsp;a clinician's evolving mental model of a patient's illness&amp;nbsp;-&amp;nbsp;has helped frame how we teach reasoning to trainees. Despite PR's popularity and promise as an educational tool, its use has also prompted persistent questions about terminology, teaching methods, and its role in developing diagnostic expertise. The recent emergence of generative artificial intelligence (GAI) capable of rapidly synthesizing and summarizing clinical has raised new concerns: If GAI can perform PR, what clinical reasoning skills remain essential for learners to master? In this perspective, we explore the history, current state of the art, and projected future of PR in a world with widespread GAI use. We argue that problem representation remains a critical cognitive process for trainees to master on their path toward expertise, even as generative AI may change or improve how it is taught.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8dz04621</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>McQuade, Casey N</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
      <author>
        <name>Bonifacino, Eliana</name>
      </author>
      <author>
        <name>Olson, Andrew PJ</name>
      </author>
      <author>
        <name>Zwaan, Laura</name>
      </author>
    </item>
    <item>
      <title>Patient reported barriers and facilitators of chronic kidney disease care in Sub-Saharan Africa: a mixed methods systematic review using the COM-B model</title>
      <link>https://escholarship.org/uc/item/8219v221</link>
      <description>BackgroundIn Sub-Saharan Africa (SSA), the prevalence of chronic kidney disease (CKD) is on the rise. Treatment for CKD in SSA is characterized by delayed initiation, early discontinuation, inadequate duration of therapy, and suboptimal follow-up. To our level of understanding, evidence on the barriers and facilitators of CKD care in SSA has not been comprehensively reported and is the focus of this mixed methods systematic review.MethodsThis convergent integrated Joanna Briggs Institute (JBI) methodology for mixed systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines. Six databases were utilized and included Medline, Ovid, Cumulative Nursing and Allied Health Literature (CINAHL), EMBASE, Web of Science, and Scopus for studies. Peer-reviewed articles published in the English language between 2000 and July 30, 2024, were included. Qualitative, quantitative, or mixed-method studies that reported health care, treatment...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8219v221</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Areri, Habtamu Abera</name>
      </author>
      <author>
        <name>Ketaw, Leul Derbie</name>
      </author>
      <author>
        <name>Berhe, Hailemariam</name>
      </author>
      <author>
        <name>Gitonga, Moses Mwangi</name>
      </author>
      <author>
        <name>Kimani, Samuel</name>
      </author>
      <author>
        <name>Kariuki, Jacob</name>
      </author>
      <author>
        <name>Thompson, Lisa</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>Gary, Rebecca</name>
      </author>
    </item>
    <item>
      <title>Next-Generation Artificial Intelligence for Diagnosis</title>
      <link>https://escholarship.org/uc/item/7n40s26t</link>
      <description>This Viewpoint explains how artificial intelligence (AI) tools have the potential to do more than predict final diagnostic labels and how AI can help reduce clinician error and more accurately diagnose and manage illness.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7n40s26t</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Adler-Milstein, Julia</name>
      </author>
      <author>
        <name>Chen, Jonathan H</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
    </item>
    <item>
      <title>Electronic health record–based patient tracking by emergency medicine physicians</title>
      <link>https://escholarship.org/uc/item/7m00n7w4</link>
      <description>Objectives: Emergency medicine (EM) physicians commonly track the progress of former patients to learn about their clinical outcome. While some studies have described the behavior, little is known about the specific information sought during tracking. The objective of this study was to determine how often EM physicians track patients and the motivations, strategies, and barriers to tracking.
Methods: In June 2019 we surveyed EM physicians practicing at six hospitals. We defined patient tracking as viewing the chart of a patient who was no longer under the physician's care or contacting the patient or the patient's subsequent providers to learn about the patient's progress. The survey asked respondents how often they track patients, by what mechanisms, and for what reasons. The survey also asked what information physicians sought when tracking and what barriers to tracking exist.
Results: Of the 156 EM physicians invited to respond, 111 completed the survey (72% response rate)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7m00n7w4</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Villalba, Constanza</name>
      </author>
      <author>
        <name>Burke, Ryan C</name>
      </author>
      <author>
        <name>Gurley, Kiersten</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
      <author>
        <name>Grossman, Shamai</name>
      </author>
    </item>
    <item>
      <title>Early-life liquefied petroleum gas cooking intervention and lung function in Guatemalan children: A randomized clinical trial</title>
      <link>https://escholarship.org/uc/item/7cg934sr</link>
      <description>RATIONALE: Household air pollution is a risk factor for obstructive lung diseases.
OBJECTIVES: We estimated the effect of an early-life liquefied petroleum gas cooking intervention on childhood lung function.
METHODS: The multi-country Household Air Pollution Intervention Network trial randomized 800 pregnant women (9-19 weeks gestation, 18-34 years) in Guatemala to receive a gas cookstove and free fuel intervention or continue cooking with biomass until the child is aged 1 year. The present analysis includes only Guatemalan children. At age 3 years, we measured lung function using oscillometry at 7-41 Hertz (Tremoflo C-100, Thorasys). Outcomes were resistance and reactance at 7 Hertz, area of reactance, resistance at 19 Hertz, resistance difference between 7 and 19 Hertz, and, as exploration, resistance across frequencies. Upper airway artifacts were removed using Tremoflo software. The effect of the intervention was estimated using linear regression models, unadjusted and adjusted...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7cg934sr</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Grajeda, Laura M</name>
      </author>
      <author>
        <name>Castellanos, Keyla</name>
      </author>
      <author>
        <name>Díaz-Artiga, Anaité</name>
      </author>
      <author>
        <name>López, Maria Reneé</name>
      </author>
      <author>
        <name>Ramirez, Alexander</name>
      </author>
      <author>
        <name>Petrovick, Tatiana</name>
      </author>
      <author>
        <name>Barraza-Villarreal, Albino</name>
      </author>
      <author>
        <name>Thompson, Lisa M</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>Jabbarzadeh, Shirin</name>
      </author>
      <author>
        <name>Wang, Jiantong</name>
      </author>
      <author>
        <name>Waller, Lance</name>
      </author>
      <author>
        <name>Clark, Maggie L</name>
      </author>
      <author>
        <name>Lovvorn, Amy E</name>
      </author>
      <author>
        <name>Eckhardt, Christina M</name>
      </author>
      <author>
        <name>Hoekstra, Nadia E</name>
      </author>
      <author>
        <name>Johnson, Michael A</name>
      </author>
      <author>
        <name>Pillarisetti, Ajay</name>
      </author>
      <author>
        <name>Prada, Diddier</name>
      </author>
      <author>
        <name>Baccarelli, Andrea A</name>
      </author>
      <author>
        <name>Shen, Ye</name>
      </author>
      <author>
        <name>Knight, Jessica</name>
      </author>
      <author>
        <name>Naeher, Luke P</name>
      </author>
      <author>
        <name>Clasen, Thomas</name>
      </author>
      <author>
        <name>Peel, Jennifer</name>
      </author>
      <author>
        <name>Mccollum, Eric D</name>
      </author>
      <author>
        <name>Mccracken, John P</name>
      </author>
    </item>
    <item>
      <title>Phylogenetic diversity, functional pathways, and network interactions of ocular chlamydia-like organisms (CLOs) in trachoma-endemic Ethiopia.</title>
      <link>https://escholarship.org/uc/item/6zd89794</link>
      <description>Trachoma is the leading infectious cause of blindness worldwide and classically attributed to C&lt;i&gt;hlamydia trachomatis&lt;/i&gt; (Ct). However, other members of the phylum Chlamydiae, particularly environmental chlamydia-like organisms (CLOs), may modulate ocular ecology and influence disease outcomes. Here, we investigated CLO distribution, phylogeny, and microbiome associations among 1,059 individuals from trachoma-endemic communities in Ethiopia using targeted 16S rRNA sequencing and metagenomic shotgun sequencing. CLOs were detected in 249 (23.3%) participants of all ages and sexes and were significantly less likely to be associated with Ct or trachomatous scarring (TS) and trichiasis (TT). Phylogenetic analyses revealed extensive CLO diversity with six novel phylotypes, the most abundant of which was ancestral to &lt;i&gt;Sorochlamydiaceae&lt;/i&gt;-a family linking pathogenic &lt;i&gt;Chlamydiaceae&lt;/i&gt;, which includes the genus &lt;i&gt;Chlamydia&lt;/i&gt;, and symbionts of protists. CLO-positive microbiomes...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6zd89794</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Olagoke, Olusola</name>
      </author>
      <author>
        <name>Zheng, Xinhe</name>
      </author>
      <author>
        <name>Chung, Seongwon</name>
      </author>
      <author>
        <name>Mengistie, Hiwot Degineh</name>
      </author>
      <author>
        <name>Asfaha, Kaleb</name>
      </author>
      <author>
        <name>Read, Timothy D</name>
      </author>
      <author>
        <name>Dean, Deborah</name>
        <uri>https://orcid.org/0000-0002-4490-1746</uri>
      </author>
    </item>
    <item>
      <title>Tweaking the complex fibrogenic role of lymphocytes in IPF</title>
      <link>https://escholarship.org/uc/item/5nz6c5sm</link>
      <description>Idiopathic pulmonary fibrosis is a deadly lung disease primarily affecting aged individuals. Even though there are two U.S. Food and Drug Administration-approved drugs, nintedanib and pirfenidone, with a recent addition of another drug, nerandomilast, yet they only reduce the progress of the disease. The mean survival rate is between 5 and 7 years even after treatment with antifibrotics. Cells of lymphoid lineage have been long reported to modulate the outcome of pulmonary fibrosis. In this review, we discuss how the cell of lymphoid lineage regulates the inflammatory niche within the lungs, leading to the development and progress of pulmonary fibrosis. The review also addresses possible therapeutic strategies that can be leveraged by specifically targeting the lymphoid cells in the pulmonary fibrotic niche.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5nz6c5sm</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bhattacharyya, Aritra</name>
      </author>
      <author>
        <name>Saba, Julie D</name>
      </author>
    </item>
    <item>
      <title>Use of Paracervical Blocks for Patients Who Undergo Intrauterine Device Insertion</title>
      <link>https://escholarship.org/uc/item/5nm1257x</link>
      <description>Paracervical blocks can reduce pain during intrauterine device (IUD) insertions, but the extent and context in which they are used in practice are unclear. To evaluate paracervical block use during IUD insertions in an academic health system. This retrospective cross-sectional time-series study was performed at the University of California, San Francisco (UCSF), academic health care system using electronic health record data. Participants included individuals who underwent IUD insertions between July 2, 2012, and August 16, 2024. Data were analyzed from October 2023 to April 2025. Clinic-, clinician-, and patient-level variables. Paracervical block receipt was determined from clinical notes. Associations of paracervical block receipt with variables at the clinic, clinician, and patient levels were estimated with multilevel models. The role of clinic specialty (pediatrics or adolescent medicine vs all other specialties) in accounting for the association of age less than 18 years...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5nm1257x</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Roger, Jacquelyn M</name>
      </author>
      <author>
        <name>Costello, Jean</name>
      </author>
      <author>
        <name>Young, Halle</name>
      </author>
      <author>
        <name>Malave-Mendez, Thaybeth I</name>
      </author>
      <author>
        <name>Miao, Brenda Y</name>
      </author>
      <author>
        <name>Brindis, Claire D</name>
      </author>
      <author>
        <name>Meckstroth, Karen</name>
      </author>
      <author>
        <name>Hernandez, Ryan D</name>
      </author>
      <author>
        <name>Whetstone, Sara</name>
      </author>
      <author>
        <name>Raymond-Flesch, Marissa</name>
      </author>
      <author>
        <name>Capra, John A</name>
      </author>
      <author>
        <name>Glymour, M Maria</name>
      </author>
      <author>
        <name>Torgerson, Dara</name>
      </author>
    </item>
    <item>
      <title>Bots and fake participants: ensuring valid and reliable data collection using online participant recruitment methods</title>
      <link>https://escholarship.org/uc/item/5n80x1bb</link>
      <description>Recruitment for successful health sciences research requires balancing efficiency, cost, accessibility, and reliability of available recruitment methods. Our case-control study used online recruitment methods, which broadened our reach to potential participants across the United States. However, this approach also exposed us to challenges associated with bot interference and fraudulent participation. This paper focuses on maintaining data integrity, specifically when utilizing online participant recruitment methods. Drawing from our experience, we propose The Swiss Cheese Model of Study Participant Fraud Prevention, adapted from Reason's Swiss Cheese Model, and illustrate ten prevention and verification measures that can be taken to minimize fraud in research studies that rely on online recruitment. We emphasize the importance of a layered approach, including carefully designed recruitment media and compensation protocols, vetting of participant eligibility, and data verification...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5n80x1bb</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Louis, Roseline Jean</name>
      </author>
      <author>
        <name>Thompson, Lisa M</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
    </item>
    <item>
      <title>C-Type Natriuretic Peptide Derivatives: Orthopaedic Implications in Achondroplasia</title>
      <link>https://escholarship.org/uc/item/4x95q78x</link>
      <description>The recent development of C-type natriuretic peptide (CNP) analogs to increase growth velocity in achondroplasia is now being used alongside limb lengthening procedures. Animal studies have shown that CNP analogs may affect bone density and the speed of callus consolidation during fracture healing. Although achondroplasia is primarily associated with a defect in endochondral ossification, pharmaceutical treatments for the condition may also influence intramembranous ossification. The availability of these non-surgical treatments warrants further investigation into their potential impact on surgical risks and outcomes. Data suggest they may affect bone quality, healing, and anatomical parameters such as medullary canal area, which could influence treatment decisions and surgical planning. This review aims to synthesize current evidence on CNP analog pathways and their intersection with biological processes involved in the surgical management of children with achondroplasia. Key...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4x95q78x</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Qian, Emily</name>
      </author>
      <author>
        <name>Chen, Kevin</name>
      </author>
      <author>
        <name>Montoya, Rachel</name>
      </author>
      <author>
        <name>Sabharwal, Sanjeev</name>
      </author>
    </item>
    <item>
      <title>Unleashing Diffusion and State Space Models for Medical Image Segmentation</title>
      <link>https://escholarship.org/uc/item/3qt4s632</link>
      <description>Existing segmentation models trained on a single medical imaging dataset often lack robustness when encountering unseen organs or tumors. Developing a robust model capable of identifying rare or novel tumor categories not present during training is crucial for advancing medical imaging applications. We propose DSM, a novel framework that leverages diffusion and state space models to segment unseen tumor categories beyond the training data. DSM utilizes two sets of object queries trained within modified attention decoders to enhance classification accuracy. Initially, the model learns organ queries using an object-aware feature grouping strategy to capture organ-level visual features. It then refines tumor queries by focusing on diffusion-based visual prompts, enabling precise segmentation of previously unseen tumors. Furthermore, we incorporate diffusion-guided feature fusion to improve semantic segmentation performance. By integrating CLIP text embeddings, DSM captures category-sensitive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3qt4s632</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Rong</name>
      </author>
      <author>
        <name>Chen, Ziqi</name>
      </author>
      <author>
        <name>Zhong, Liming</name>
      </author>
      <author>
        <name>Li, Heng</name>
      </author>
      <author>
        <name>Shu, Hai</name>
      </author>
    </item>
    <item>
      <title>Personal household air pollution exposure and SARS-CoV-2 antibody responses among women and infants: an analysis within the HAPIN trial</title>
      <link>https://escholarship.org/uc/item/2kd6202w</link>
      <description>Background While extensive research has linked ambient air pollution to increased COVID-19 infection rates and severity, the role of household air pollution (HAP)—a major public health exposure affecting nearly 3 billion people globally—remains understudied. Here, we evaluate associations between a clean cooking intervention, personal household air pollution exposure, and serologic evidence of prior SARS-CoV-2 infection using exploratory intention-to-treat and exposure–response analyses. Methods The Household Air Pollution Intervention Network (HAPIN) Trial randomized 3,200 households in Guatemala, India, Peru, and Rwanda to either continue using traditional solid fuel cookstoves or receive liquefied petroleum gas stoves with continuous fuel supply and behavioral messaging. The current ancillary study leveraged personal exposures to PM2.5 and carbon monoxide (CO) and dried blood spot (DBS) samples collected in the Guatemala, India, and Peru HAPIN sites to study the association...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2kd6202w</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Underhill, Lindsay J</name>
      </author>
      <author>
        <name>Clark, Maggie L</name>
      </author>
      <author>
        <name>Barr, Dana Boyd</name>
      </author>
      <author>
        <name>Balakrishnan, Kalpana</name>
      </author>
      <author>
        <name>Puttaswamy, Naveen</name>
      </author>
      <author>
        <name>Pillarisetti, Ajay</name>
      </author>
      <author>
        <name>Diaz-Artiga, Anaite A</name>
      </author>
      <author>
        <name>Thompson, Lisa M</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>McCracken, John P</name>
      </author>
      <author>
        <name>Davila-Roman, Victor G</name>
      </author>
      <author>
        <name>Waller, Lance A</name>
      </author>
      <author>
        <name>Young, Bonnie N</name>
      </author>
      <author>
        <name>Johnson, Michael A</name>
      </author>
      <author>
        <name>Rajamani, Karthikeyan</name>
      </author>
      <author>
        <name>Checkley, William</name>
      </author>
      <author>
        <name>Clasen, Thomas F</name>
      </author>
      <author>
        <name>Peel, Jennifer L</name>
      </author>
      <author>
        <name>Steenland, Kyle</name>
      </author>
      <author>
        <name>Investigators*, On behalf of the HAPIN</name>
      </author>
    </item>
    <item>
      <title>The VA My Life My Story Project: Keeping Medical Students and Veterans Socially Connected While Physically Distanced.</title>
      <link>https://escholarship.org/uc/item/29r8w4gq</link>
      <description>INTRODUCTION: Narrative competence comprises the skills of acknowledging, interpreting, and acting on the stories of others. Developing narrative competence is integral to providing patient-centered care. In January 2020, we designed a narrative medicine curriculum in which medical students at the San Francisco Veteran Affairs (VA) Medical Center in California participated as interviewers in My Life My Story (MLMS) program. The curricular objectives for medical students were to build life story skills, appreciate the impact of storytelling on a veteran's health care experience, and understand the VA mission.
OBSERVATIONS: Students attended a training session to build narrative medicine skills, interviewed a veteran, entered their life story into the health record, and attended a second session to debrief. Students completed a survey after the MLMS program. From March to July 2020, COVID-19-related restrictions prompted transition of the program to a virtual format. Sixty-two veteran...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/29r8w4gq</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Walker, Evan</name>
      </author>
      <author>
        <name>Bruns, Elizabeth</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
    </item>
    <item>
      <title>“A place to have fellowship”: implementing group counseling in a clinical fellowship program</title>
      <link>https://escholarship.org/uc/item/1xj0k8cp</link>
      <description>BackgroundThe American College of Graduate Medical Education (ACGME) has endorsed recommendations to promote individual counseling services to support trainees. However, there are limited data and no clear recommendations related to group counseling services, a format that may be scalable and support peer connection. This paper has two primary objectives: (1) to describe the implementation of group counseling as a method of providing formative, normative, and restorative supervision to GME trainees and (2) to report participants’ experiences within the program.MethodsIn September 2019, the fellowship program implemented regular group counseling for fellows, with ongoing feedback collected to optimize logistics. Between November 2023 and January 2024, we worked within an interpretivist paradigm to explore experiences with group counseling by conducting semi-structured individual interviews with former and current fellows, which were transcribed and analyzed thematically. This study...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1xj0k8cp</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sinha, Anoushka</name>
        <uri>https://orcid.org/0000-0002-0967-6870</uri>
      </author>
      <author>
        <name>Buckelew, Sara M</name>
      </author>
      <author>
        <name>Raymond-Flesch, Marissa</name>
      </author>
    </item>
    <item>
      <title>Dietary tryptophan mitigates lung ischemia-reperfusion injury via microbiota-derived indole-3-propionate and aryl hydrocarbon receptor signaling.</title>
      <link>https://escholarship.org/uc/item/0nm5655x</link>
      <description>Background: Lung ischemia-reperfusion (IR) injury drives early morbidity after lung transplantation and cardiothoracic surgery, yet targeted preventive therapies are lacking. The gut-lung axis and microbiota-derived tryptophan metabolites, including indole-3-propionate (IPA), may regulate pulmonary immunity and inflammation. We investigated whether a tryptophan-rich (Trp-Rich) diet attenuates sterile lung IR injury by increasing microbiota-derived indole metabolites and reprogramming alveolar macrophage (AM) inflammatory responses.
Methods: C57BL/6 mice received isocaloric tryptophan-standard (Trp-Std; 0.18%) or Trp-Rich (0.60%) diets for 14 days, then underwent unilateral left lung IR (60 min ischemia followed by 60 min reperfusion). Oxygen saturation, lung cytokines, and aryl hydrocarbon receptor (AhR) signaling readouts ( &lt;i&gt;Cyp1a1&lt;/i&gt; / &lt;i&gt;Cyp1b1&lt;/i&gt; ) were evaluated. Gut microbiota was profiled by 16S rRNA sequencing, and targeted metabolomics quantified tryptophan metabolites...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0nm5655x</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chaki, Tomohiro</name>
      </author>
      <author>
        <name>Maruyama, Daisuke</name>
      </author>
      <author>
        <name>Doan, Thien NM</name>
      </author>
      <author>
        <name>Xiaoli, Tian</name>
      </author>
      <author>
        <name>Prakash, Arun</name>
      </author>
    </item>
    <item>
      <title>Exploitive Adolescent Labor and Labor Trafficking: Clinical Perspectives for Adolescent Healthcare Providers</title>
      <link>https://escholarship.org/uc/item/0km7h7ch</link>
      <description>Exploitive Adolescent Labor and Labor Trafficking: Clinical Perspectives for Adolescent Healthcare Providers</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0km7h7ch</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Barral, Romina</name>
      </author>
      <author>
        <name>Kelley, Michele A</name>
      </author>
      <author>
        <name>English, Abigail</name>
      </author>
      <author>
        <name>Raymond-Flesch, Marissa</name>
      </author>
      <author>
        <name>Chaffee, Tonya</name>
      </author>
      <author>
        <name>Svetaz, Veronica</name>
      </author>
      <author>
        <name>Coyne-Beasley, Tamera</name>
      </author>
      <author>
        <name>Kanbur, Nuray</name>
      </author>
    </item>
    <item>
      <title>Exposure–response relationship of household air pollution on body mass index among women in rural areas of Guatemala, India, Peru and Rwanda: household air pollution intervention network trial</title>
      <link>https://escholarship.org/uc/item/0dx4w6r4</link>
      <description>BackgroundHousehold air pollution from burning biomass materials, the main cooking fuel in low- and middle-income countries, may be linked to metabolic dysfunction. We assessed cross-sectional associations between household air pollution and body mass index (BMI), expecting to see increased BMI with higher pollution concentrations.MethodsWe analyzed data from 414 women aged 40 to 79&amp;nbsp;years who resided in the households using biomass fuel and were enrolled in the multi-country Household Air Pollution Intervention Network&amp;nbsp;(HAPIN)&amp;nbsp;Trial. We explored associations of 24-h average personal exposure to fine particulate matter (PM2.5), black carbon (BC), and carbon monoxide (CO) with BMI through single pollutant linear and logistic models adjusted for potential confounders (i.e., age, socioeconomic indicators, education, dietary diversity, secondhand smoke exposure, alcohol and grain consumption).Sensitivity analyses explored air pollutants as quartiles, and other variables...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0dx4w6r4</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Ndikubwimana, Adolphe</name>
      </author>
      <author>
        <name>Checkley, William</name>
      </author>
      <author>
        <name>Chen, Yunyun</name>
      </author>
      <author>
        <name>Clasen, Thomas</name>
      </author>
      <author>
        <name>Contreras, Carmen Lucía</name>
      </author>
      <author>
        <name>Diaz-Artiga, Anaite</name>
      </author>
      <author>
        <name>Dusabimana, Ephrem</name>
      </author>
      <author>
        <name>de las Fuentes, Lisa</name>
      </author>
      <author>
        <name>Jabbarzadeh, Shirin</name>
      </author>
      <author>
        <name>Johnson, Michael</name>
      </author>
      <author>
        <name>Kalisa, Egide</name>
      </author>
      <author>
        <name>Karakwende, Patrick</name>
      </author>
      <author>
        <name>Kirby, Miles</name>
      </author>
      <author>
        <name>Lovvorn, Amy E</name>
      </author>
      <author>
        <name>McCracken, John P</name>
      </author>
      <author>
        <name>Ndagijimana, Florien</name>
      </author>
      <author>
        <name>Ntakirutimana, Theoneste</name>
      </author>
      <author>
        <name>Ntivuguruzwa, Jean Dieu</name>
      </author>
      <author>
        <name>Peel, Jennifer L</name>
      </author>
      <author>
        <name>Pillarisetti, Ajay</name>
      </author>
      <author>
        <name>Dávila-Román, Victor G</name>
      </author>
      <author>
        <name>Rosa, Ghislaine</name>
      </author>
      <author>
        <name>Garg, Sarada S</name>
      </author>
      <author>
        <name>Thompson, Lisa</name>
        <uri>https://orcid.org/0000-0002-8001-2057</uri>
      </author>
      <author>
        <name>Waller, Lance A</name>
      </author>
      <author>
        <name>Wang, Jiantong</name>
      </author>
      <author>
        <name>Clark, Maggie L</name>
      </author>
      <author>
        <name>Young, Bonnie N</name>
      </author>
    </item>
    <item>
      <title>Barriers and Facilitators to Higher Education Applications and Admissions Among People in Recovery</title>
      <link>https://escholarship.org/uc/item/5mf7480m</link>
      <description>People in substance use disorder recovery represent a marginalized and underserved student population. Improving access to higher education for people in recovery can benefit the individual, institution, and society at large. This study explored the barriers to college applications and admissions that people in recovery face and the resources that they draw on to overcome these barriers. Semistructured interviews were completed with 17 undergraduate students in recovery at a large public university without a collegiate recovery program. Inductive thematic analysis was used to document students' experiences related to applications and admissions. Participants described barriers to higher education at multiple levels, including personal challenges (e.g., competing priorities), consequences of past use (e.g., a record of criminal legal system involvement), challenges in the social environment (e.g., substance use on campus), complex admission processes (e.g., regarding transfer credits),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5mf7480m</guid>
      <pubDate>Tue, 5 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pasman, Emily</name>
      </author>
      <author>
        <name>Gannon, Kim</name>
        <uri>https://orcid.org/0000-0002-0867-5358</uri>
      </author>
      <author>
        <name>Broman, Michael</name>
      </author>
      <author>
        <name>Cox, Erin</name>
      </author>
      <author>
        <name>Brown, Suzanne</name>
      </author>
      <author>
        <name>Patterson, Debra</name>
      </author>
      <author>
        <name>Agius, Elizabeth</name>
      </author>
      <author>
        <name>Resko, Stella M</name>
      </author>
    </item>
    <item>
      <title>Anti-Latine bias and drug-induced homicide law support: Evidence from a nationally diverse, randomized survey experiment in the United States</title>
      <link>https://escholarship.org/uc/item/2b89262t</link>
      <description>Anti-Latine bias and drug-induced homicide law support: Evidence from a nationally diverse, randomized survey experiment in the United States</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2b89262t</guid>
      <pubDate>Tue, 5 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gannon, Kim</name>
        <uri>https://orcid.org/0000-0002-0867-5358</uri>
      </author>
      <author>
        <name>Gonsalves, Gregg</name>
      </author>
      <author>
        <name>Busch, Susan H</name>
      </author>
      <author>
        <name>Schlesinger, Mark J</name>
        <uri>https://orcid.org/0000-0002-7142-8667</uri>
      </author>
    </item>
    <item>
      <title>“Knowing or not knowing”: Living as harm reductionists in Twelve Step recovery</title>
      <link>https://escholarship.org/uc/item/1rb1173g</link>
      <description>“Knowing or not knowing”: Living as harm reductionists in Twelve Step recovery</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rb1173g</guid>
      <pubDate>Tue, 5 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gannon, Kim</name>
        <uri>https://orcid.org/0000-0002-0867-5358</uri>
      </author>
      <author>
        <name>Pasman, Emily</name>
      </author>
    </item>
    <item>
      <title>Beyond the 5-year recovery mark: Perspectives of researchers with lived and living experience on public engagement and discourse</title>
      <link>https://escholarship.org/uc/item/0fs4k950</link>
      <description>There has been growing attention toward including people with lived and living experience (PWLLE) with substance use, substance use disorders, and recovery in public-facing activities. The goals of including PWLLE in sharing their perspectives often include demonstrating that recovery is possible, destigmatizing and humanizing people who have substance use experiences, and leveraging their lived experience to illuminate a particular topic or issue. Recently, the National Council for Mental Wellbeing issued a set of guidelines entitled, "Protecting Individuals with Lived Experience in Public Disclosure," which included a "Lived Experience Safeguard Scale." We offer the present commentary to bolster some of the ideas presented by the Council and to articulate suggested changes to this guidance, with the goal of reducing unintentional gatekeeping and stigma. Specifically, we offer that there are numerous problems with the recommendation to only invite people who have "five or more...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0fs4k950</guid>
      <pubDate>Tue, 5 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cioffi, Camille C</name>
      </author>
      <author>
        <name>Flinn, Ryan E</name>
      </author>
      <author>
        <name>Pasman, Emily</name>
      </author>
      <author>
        <name>Gannon, Kim</name>
        <uri>https://orcid.org/0000-0002-0867-5358</uri>
      </author>
      <author>
        <name>Gold, Dudi</name>
      </author>
      <author>
        <name>McCabe, Sean Esteban</name>
      </author>
      <author>
        <name>Kepner, Wayne</name>
      </author>
      <author>
        <name>Tillson, Martha</name>
      </author>
      <author>
        <name>Colditz, Jason B</name>
      </author>
      <author>
        <name>Smith, Douglas C</name>
      </author>
      <author>
        <name>Bohler, Robert M</name>
      </author>
      <author>
        <name>O'Donnell, Joseph E</name>
      </author>
      <author>
        <name>Hildebran, Christi</name>
      </author>
      <author>
        <name>Montgomery, Barrett Wallace</name>
      </author>
      <author>
        <name>Clingan, Sarah</name>
      </author>
      <author>
        <name>Lofaro, Ryan J</name>
      </author>
    </item>
    <item>
      <title>Medications for opioid use disorder and other evidence-based service offerings in faith-affiliated treatment centers: Implications for implementation partnerships</title>
      <link>https://escholarship.org/uc/item/0f99q8jf</link>
      <description>INTRODUCTION: Amidst an ongoing surge of opioid use disorder (OUD) incidence, clinicians and policymakers are seeking partnerships with faith communities - including with faith-affiliated treatment centers (FATCs) - to expand access to evidence-based OUD treatment. However, little is known whether FATCs differentially offer such evidence-based treatment services, particularly medications for opioid use disorder (MOUD) and co-occurring mental health care.
METHODS: We use the 2021 National Substance Use and Mental Health Services Survey (N-SUMHSS) to examine differences in provision of several OUD services, including MOUD, psychological treatments, mental health services, medical services, recovery support services, and services related to treatment accessibility, between self-identified FATCs and non-FATCs. We also explored differences in characteristics related to insurance, licensure, and accreditation.
RESULTS: FATCs were less likely than non-FATCs to offer almost all measure...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0f99q8jf</guid>
      <pubDate>Tue, 5 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Gannon, Kim</name>
        <uri>https://orcid.org/0000-0002-0867-5358</uri>
      </author>
      <author>
        <name>Warnock, Charles A</name>
      </author>
    </item>
    <item>
      <title>Integrating Mobile Text Messaging Pre-Exposure Prophylaxis Navigation Services Into a Home HIV and Sexually Transmitted Infection Self-Testing Program in the United States: Formative Work and Pilot Implementation Study.</title>
      <link>https://escholarship.org/uc/item/9pw1q1gk</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;HIV testing is the gateway to the HIV prevention continuum and offers an important opportunity to provide HIV prevention services. TakeMeHome.org is an online program that enables state and local health departments to offer free in-home HIV and sexually transmitted infection self-testing. As few TakeMeHome users have used pre-exposure prophylaxis (PrEP), there is an opportunity to link TakeMeHome users to PrEP information and services.&lt;h4&gt;Objective&lt;/h4&gt;The aim of this study is to develop an implementation strategy to link HIV or sexually transmitted infection self-testers from online orders to PrEP services via direct digital linkage to a novel SMS text messaging navigation program.&lt;h4&gt;Methods&lt;/h4&gt;PrEPmate is an evidence-based bidirectional text-messaging platform that has demonstrated increased PrEP retention and adherence. We developed a novel program to link TakeMeHome testers to mobile SMS text messaging PrEP navigation via PrEPmate. We conducted focus groups...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9pw1q1gk</guid>
      <pubDate>Fri, 1 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Liu, Albert</name>
      </author>
      <author>
        <name>Alleyne, Cat-Dancing</name>
      </author>
      <author>
        <name>Moss, Juwann</name>
      </author>
      <author>
        <name>Vinson, Janie</name>
      </author>
      <author>
        <name>Lafferty, Kyle</name>
      </author>
      <author>
        <name>Quintana, Sarah</name>
      </author>
      <author>
        <name>Duenez, Nancy</name>
      </author>
      <author>
        <name>Lopez, Kaitlin</name>
      </author>
      <author>
        <name>Johannessen, Deejay</name>
      </author>
      <author>
        <name>Fraide, Anthony</name>
      </author>
      <author>
        <name>Buchbinder, Susan</name>
      </author>
      <author>
        <name>Scott, Hyman</name>
      </author>
      <author>
        <name>Glidden, Dave</name>
      </author>
      <author>
        <name>Hecht, Jen</name>
      </author>
    </item>
    <item>
      <title>Growing stronger: Nine decades of physical disability representation in children's media and implications for pediatric rehabilitation.</title>
      <link>https://escholarship.org/uc/item/5zn2k25z</link>
      <description>BackgroundChildren's media both reflects and shapes societal attitudes toward physical disability. Despite its potential impact on self-concept and stigma, longitudinal, data-driven analysis of these portrayals remains scarce. This study aimed to quantify longitudinal trends in the tone and framing of physical disability representation in children's media and to explore implications for pediatric rehabilitation.MethodsA quantitative content analysis was conducted on 68 children's media productions (1933-2025) sourced from the Vanderbilt Peabody database. Content was filtered to age-appropriate ratings (G, PG, PG-13, TV-14). Three trained reviewers classified depictions of physical disability by clinical category (e.g., spinal cord injury, limb difference) and tone (Positive, Neutral, Negative) and coded for the presence of rehabilitation themes. Inter-rater reliability (κ = 0.83) was achieved. Statistical testing included Mann-Kendall trend analysis and Fisher's exact tests to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5zn2k25z</guid>
      <pubDate>Mon, 27 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tahseen, Danyal</name>
      </author>
      <author>
        <name>Saenz, Amanda</name>
      </author>
      <author>
        <name>Hijazi, Rhoda</name>
      </author>
      <author>
        <name>Wu, Jasmine</name>
      </author>
      <author>
        <name>Davis, Taron</name>
      </author>
    </item>
    <item>
      <title>Genetic modifiers of APOE-ε4-associated cognitive decline</title>
      <link>https://escholarship.org/uc/item/5rz2g2n4</link>
      <description>The APOE-ε4 allele is the strongest genetic risk factor for late-onset Alzheimer’s disease. However, APOE-ε4 is not deterministic, highlighting the need to identify additional genetic and environmental factors. APOE-ε4 has been linked to accelerated cognitive decline, so we sought to investigate genetic factors that modify APOE-ε4–associated cognitive decline. We conduct cross-ancestry APOE-ε4-stratified and interaction GWAS using harmonized cognitive data from 32,778 participants, including 29,354 non-Hispanic White and 3,424 non-Hispanic Black individuals. Our primary outcome is late-life cognition, measured using harmonized composite scores for memory, executive function, and language, modeled as continuous traits reflecting both normative cognitive aging and disease-related decline. We identify two genome-wide significant loci in APOE-ε4 carriers, reaching genome-wide significance for executive function. These loci also demonstrate nominal associations across the other domains,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5rz2g2n4</guid>
      <pubDate>Mon, 27 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Contreras, Alex G</name>
      </author>
      <author>
        <name>Walters, Skylar</name>
      </author>
      <author>
        <name>Eissman, Jaclyn M</name>
      </author>
      <author>
        <name>Archer, Derek B</name>
      </author>
      <author>
        <name>Regelson, Alexandra N</name>
      </author>
      <author>
        <name>Durant, Alaina</name>
      </author>
      <author>
        <name>Clifton, Michelle</name>
      </author>
      <author>
        <name>Mukherjee, Subhabrata</name>
      </author>
      <author>
        <name>Lee, Michael L</name>
      </author>
      <author>
        <name>Choi, Seo-Eun</name>
      </author>
      <author>
        <name>Scollard, Phoebe</name>
      </author>
      <author>
        <name>Trittschuh, Emily H</name>
      </author>
      <author>
        <name>Mez, Jesse</name>
      </author>
      <author>
        <name>Bush, William S</name>
      </author>
      <author>
        <name>Kunkle, Brian W</name>
      </author>
      <author>
        <name>Cruchaga, Carlos</name>
      </author>
      <author>
        <name>Naj, Adam C</name>
      </author>
      <author>
        <name>Gifford, Katherine A</name>
      </author>
      <author>
        <name>Bilgel, Murat</name>
      </author>
      <author>
        <name>Kuzma, Amanda B</name>
      </author>
      <author>
        <name>Cuccaro, Michael L</name>
      </author>
      <author>
        <name>Pericak-Vance, Margaret A</name>
      </author>
      <author>
        <name>Farrer, Lindsay A</name>
      </author>
      <author>
        <name>Wang, Li-San</name>
      </author>
      <author>
        <name>Schellenberg, Gerard D</name>
      </author>
      <author>
        <name>Haines, Jonathan L</name>
      </author>
      <author>
        <name>Jefferson, Angela L</name>
      </author>
      <author>
        <name>Kukull, Walter A</name>
      </author>
      <author>
        <name>Keene, C Dirk</name>
      </author>
      <author>
        <name>Saykin, Andrew J</name>
      </author>
      <author>
        <name>Thompson, Paul M</name>
      </author>
      <author>
        <name>Martin, Eden R</name>
      </author>
      <author>
        <name>Albert, Marilyn S</name>
      </author>
      <author>
        <name>Johnson, Sterling C</name>
      </author>
      <author>
        <name>Engelman, Corinne D</name>
      </author>
      <author>
        <name>Ferrucci, Luigi</name>
      </author>
      <author>
        <name>Bennett, David A</name>
      </author>
      <author>
        <name>Barnes, Lisa L</name>
      </author>
      <author>
        <name>Schneider, Julie A</name>
      </author>
      <author>
        <name>Sperling, Reisa A</name>
      </author>
      <author>
        <name>Resnick, Susan M</name>
      </author>
      <author>
        <name>Crane, Paul K</name>
      </author>
      <author>
        <name>Dumitrescu, Logan</name>
      </author>
      <author>
        <name>Hohman, Timothy J</name>
      </author>
    </item>
    <item>
      <title>Recurrent episodes of pneumonia are associated with worse lung function in people with HIV.</title>
      <link>https://escholarship.org/uc/item/57v4582r</link>
      <description>BACKGROUND: HIV is associated with a decreased diffusing capacity for carbon monoxide (DLco), decreased spirometry, and an increased risk for developing obstructive lung disease, even in never-smokers. Pneumonia is a risk factor for impaired pulmonary function in people with HIV (PWH), but whether recurrent pneumonia results in a commensurate decline in lung function is unknown.
METHODS: We reviewed the electronic medical records and PFT data for PWH in San Francisco, CA. Participants were categorized by number of pneumonias since HIV diagnosis. We analyzed the association between the number of pneumonias and lung function using linear and logistic regression models after adjusting for substance use and HIV-associated factors.
RESULTS: Among 259 participants, the mean age was 51 years, 15% were female, and 42% were current smokers. One hundred (39%) participants had no prior pneumonia, 52 (20%) had 1 pneumonia, 50 (19%) had 2 pneumonias and 57 (22%) had ≥3 pneumonias. Multiple...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/57v4582r</guid>
      <pubDate>Sat, 25 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Walderich, Sven J</name>
      </author>
      <author>
        <name>Fitzpatrick-Collins, Jessica</name>
      </author>
      <author>
        <name>Bates, Aryana</name>
      </author>
      <author>
        <name>Zhang, Michelle H</name>
      </author>
      <author>
        <name>Branchini, Jake</name>
      </author>
      <author>
        <name>Gardner, Kendall</name>
      </author>
      <author>
        <name>Bhide, Sharvari</name>
      </author>
      <author>
        <name>Jan, Amanda</name>
      </author>
      <author>
        <name>Abelman, Rebecca</name>
      </author>
      <author>
        <name>Byanova, Katerina L</name>
        <uri>https://orcid.org/0000-0001-6739-1120</uri>
      </author>
      <author>
        <name>Huang, Laurence</name>
        <uri>https://orcid.org/0000-0003-3888-2195</uri>
      </author>
    </item>
    <item>
      <title>297: High-dose misoprostol with subsequent foley versus low-dose misoprostol with concurrent foley for cervical ripening</title>
      <link>https://escholarship.org/uc/item/8ng9d0r6</link>
      <description>297: High-dose misoprostol with subsequent foley versus low-dose misoprostol with concurrent foley for cervical ripening</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8ng9d0r6</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Zakama, Arthurine</name>
      </author>
      <author>
        <name>Sobhani, Nasim</name>
      </author>
      <author>
        <name>Rosenstein, Melissa G</name>
      </author>
      <author>
        <name>Lamar, Robyn</name>
      </author>
    </item>
    <item>
      <title>Palliative Care Intervention for Patients With End-Stage Liver Disease</title>
      <link>https://escholarship.org/uc/item/6v36q88x</link>
      <description>Importance: Palliative care improves quality of life (QoL) in advanced illnesses, but data in end-stage liver disease (ESLD) are limited. It is unknown whether palliative care delivered by hepatologists is effective when compared with palliative care specialists.
Objective: To compare the effectiveness of palliative care delivered by trained hepatologists with the care delivered by conventional palliative care specialists in improving QoL at 3 months.
Design, Setting, and Participants: This comparative effectiveness cluster randomized trial for US patients treated for ESLD in 19 US medical centers compared a palliative care intervention delivered by palliative care-trained hepatologists (hepatologist group; 11 centers) with palliative care specialists (consultative group; 8 centers). Eligible patients were US adults with either decompensated cirrhosis or hepatocellular cancer who had a life expectancy of at least 6 months, had not received or scheduled liver transplantation, or...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6v36q88x</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Verma, Manisha</name>
      </author>
      <author>
        <name>Navarro, Victor</name>
      </author>
      <author>
        <name>Kosinski, Andrzej</name>
      </author>
      <author>
        <name>Taddei, Tamar</name>
      </author>
      <author>
        <name>Kalman, Richard</name>
      </author>
      <author>
        <name>Barritt, A Sidney</name>
      </author>
      <author>
        <name>Jakab, Simona</name>
      </author>
      <author>
        <name>Serper, Marina</name>
      </author>
      <author>
        <name>Orman, Eric</name>
      </author>
      <author>
        <name>Balakrishnan, Maya</name>
      </author>
      <author>
        <name>Rakoski, Mina</name>
      </author>
      <author>
        <name>Rockey, Don</name>
      </author>
      <author>
        <name>Hunt, Kristel</name>
      </author>
      <author>
        <name>Cabrera, Roniel</name>
      </author>
      <author>
        <name>Aytaman, Ayse</name>
      </author>
      <author>
        <name>John, Binu</name>
      </author>
      <author>
        <name>Baffy, Gyorgy</name>
      </author>
      <author>
        <name>Nathan, Rohit</name>
      </author>
      <author>
        <name>Tapper, Elliot</name>
      </author>
      <author>
        <name>Roytman, Marina</name>
      </author>
      <author>
        <name>McGuire, Brendan</name>
      </author>
      <author>
        <name>Hoppmann, Nicholas</name>
      </author>
      <author>
        <name>Woodrell, Christopher</name>
      </author>
      <author>
        <name>Bakitas, Marie</name>
      </author>
      <author>
        <name>Yue, Yang</name>
      </author>
      <author>
        <name>Reeve, Bryce</name>
      </author>
      <author>
        <name>Lin, Li</name>
      </author>
      <author>
        <name>Tantala, Rebecca</name>
      </author>
      <author>
        <name>Volk, Michael</name>
      </author>
    </item>
    <item>
      <title>HIVST in the presence of a partner among fishermen in Western Kenya: A qualitative study</title>
      <link>https://escholarship.org/uc/item/4wj190d3</link>
      <description>BACKGROUND: HIV self-testing (HIVST) enables individuals to test privately and can serve as an important tool to mitigate stigma and fear of HIV testing and unintended disclosure, especially among men, who have lower voluntary testing rates than women.
AIM: Within an intervention study involving distribution of HIVST kits by fishermen to their peers [NCT04772469], we explore the experiences and the motivations of men who chose to self-test for HIV in the presence of their female partners.
METHOD: We conducted in-depth interviews (&lt;i&gt;n&lt;/i&gt; = 32) with fishermen from three fishing communities along Lake Victoria, Kenya. Interviews were conducted at three months post-intervention and explored fishermen's experiences with HIVST and the context under which they tested. Interviews were analysed using a framework analysis approach.
RESULTS: Though they were not prompted by the study to do so, 17 participants described testing for HIV at home in the presence of partners. Fishermen who...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wj190d3</guid>
      <pubDate>Fri, 24 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Abade, Peter</name>
      </author>
      <author>
        <name>Olugo, Phoebe</name>
      </author>
      <author>
        <name>Gutin, Sarah A</name>
        <uri>https://orcid.org/0000-0002-7634-1296</uri>
      </author>
      <author>
        <name>Nishimura, Holly</name>
        <uri>https://orcid.org/0000-0001-6572-5473</uri>
      </author>
      <author>
        <name>Lewis-Kulzer, Jayne</name>
      </author>
      <author>
        <name>Thorp, Marguerite</name>
      </author>
      <author>
        <name>Ayieko, Benard</name>
      </author>
      <author>
        <name>Oluoch, Lennah</name>
      </author>
      <author>
        <name>Angawa, David</name>
      </author>
      <author>
        <name>Camlin, Carol S</name>
        <uri>https://orcid.org/0000-0001-5615-1164</uri>
      </author>
      <author>
        <name>Kwena, Zachary A</name>
      </author>
    </item>
    <item>
      <title>ABCC1 protects skin dendritic cells from FITC-induced toxicity by efflux and extracellular glutathione buffering</title>
      <link>https://escholarship.org/uc/item/9985t3ms</link>
      <description>Dendritic cell (DC) migration is critical for initiating adaptive immune responses. Previous work suggested a role for ATP-binding cassette transporter C1 (ABCC1) in skin DC migration following cutaneous fluorescein isothiocyanate (FITC) exposure, but the precise mechanism involved was unclear. Here, we establish that the primary contribution of ABCC1 to skin DC function following FITC exposure is not modulation of migration, but enhancement of survival. Our findings demonstrate that ABCC1 operates on a dual level: Intracellularly, by transporting toxic FITC and fluorescein out of DCs, and extracellularly, by contributing to a glutathione (GSH) buffer zone that protects surrounding cells. DCs are particularly susceptible to FITC-mediated toxicity, possibly due to their high endocytic activity. This study elucidates the critical dependence of DCs on ABCC1 and extracellular GSH for resistance to toxic organic molecules and thereby identifies potential therapeutic avenues targeting...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9985t3ms</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Knöpper, Konrad</name>
      </author>
      <author>
        <name>Rao, Anshul</name>
      </author>
      <author>
        <name>An, Jinping</name>
      </author>
      <author>
        <name>Cyster, Jason G</name>
      </author>
    </item>
    <item>
      <title>The 2024 Brain Tumor Segmentation (BraTS) Challenge: Glioma Segmentation on Post-treatment MRI</title>
      <link>https://escholarship.org/uc/item/9961p1k9</link>
      <description>Gliomas are the most common malignant primary brain tumors in adults and one of the deadliest types of cancer. There are many challenges in treatment and monitoring due to the genetic diversity and high intrinsic heterogeneity in appearance, shape, histology, and treatment response. Treatments include surgery, radiation, and systemic therapies, with magnetic resonance imaging (MRI) playing a key role in treatment planning and post-treatment longitudinal assessment. The 2024 Brain Tumor Segmentation (BraTS) challenge on post-treatment glioma MRI will provide a community standard and benchmark for state-of-the-art automated segmentation models based on the largest expert-annotated post-treatment glioma MRI dataset. Challenge competitors will develop automated segmentation models to predict four distinct tumor sub-regions consisting of enhancing tissue (ET), surrounding non-enhancing T2/fluid-attenuated inversion recovery (FLAIR) hyperintensity (SNFH), non-enhancing tumor core (NETC),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9961p1k9</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>de Verdier, Maria Correia</name>
      </author>
      <author>
        <name>Saluja, Rachit</name>
      </author>
      <author>
        <name>Gagnon, Louis</name>
      </author>
      <author>
        <name>LaBella, Dominic</name>
      </author>
      <author>
        <name>Baid, Ujjwall</name>
      </author>
      <author>
        <name>Tahon, Nourel Hoda</name>
      </author>
      <author>
        <name>Foltyn-Dumitru, Martha</name>
      </author>
      <author>
        <name>Zhang, Jikai</name>
      </author>
      <author>
        <name>Alafif, Maram</name>
      </author>
      <author>
        <name>Baig, Saif</name>
      </author>
      <author>
        <name>Chang, Ken</name>
      </author>
      <author>
        <name>D'Anna, Gennaro</name>
      </author>
      <author>
        <name>Deptula, Lisa</name>
      </author>
      <author>
        <name>Gupta, Diviya</name>
      </author>
      <author>
        <name>Haider, Muhammad Ammar</name>
      </author>
      <author>
        <name>Hussain, Ali</name>
      </author>
      <author>
        <name>Iv, Michael</name>
      </author>
      <author>
        <name>Kontzialis, Marinos</name>
      </author>
      <author>
        <name>Manning, Paul</name>
      </author>
      <author>
        <name>Moodi, Farzan</name>
      </author>
      <author>
        <name>Nunes, Teresa</name>
      </author>
      <author>
        <name>Simon, Aaron</name>
      </author>
      <author>
        <name>Sollmann, Nico</name>
      </author>
      <author>
        <name>Vu, David</name>
      </author>
      <author>
        <name>Adewole, Maruf</name>
      </author>
      <author>
        <name>Albrecht, Jake</name>
      </author>
      <author>
        <name>Anazodo, Udunna</name>
      </author>
      <author>
        <name>Chai, Rongrong</name>
      </author>
      <author>
        <name>Chung, Verena</name>
      </author>
      <author>
        <name>Faghani, Shahriar</name>
      </author>
      <author>
        <name>Farahani, Keyvan</name>
      </author>
      <author>
        <name>Kazerooni, Anahita Fathi</name>
      </author>
      <author>
        <name>Iglesias, Eugenio</name>
      </author>
      <author>
        <name>Kofler, Florian</name>
      </author>
      <author>
        <name>Li, Hongwei</name>
      </author>
      <author>
        <name>Linguraru, Marius George</name>
      </author>
      <author>
        <name>Menze, Bjoern</name>
      </author>
      <author>
        <name>Moawad, Ahmed W</name>
      </author>
      <author>
        <name>Velichko, Yury</name>
      </author>
      <author>
        <name>Wiestler, Benedikt</name>
      </author>
      <author>
        <name>Altes, Talissa</name>
      </author>
      <author>
        <name>Basavasagar, Patil</name>
      </author>
      <author>
        <name>Bendszus, Martin</name>
      </author>
      <author>
        <name>Brugnara, Gianluca</name>
      </author>
      <author>
        <name>Cho, Jaeyoung</name>
      </author>
      <author>
        <name>Dhemesh, Yaseen</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Garrett, Filip</name>
      </author>
      <author>
        <name>Gass, Jaime</name>
      </author>
      <author>
        <name>Hadjiiski, Lubomir</name>
      </author>
      <author>
        <name>Hattangadi-Gluth, Jona</name>
      </author>
      <author>
        <name>Hess, Christopher</name>
        <uri>https://orcid.org/0000-0002-5132-5302</uri>
      </author>
      <author>
        <name>Houk, Jessica L</name>
      </author>
      <author>
        <name>Isufi, Edvin</name>
      </author>
      <author>
        <name>Layfield, Lester J</name>
      </author>
      <author>
        <name>Mastorakos, George</name>
      </author>
      <author>
        <name>Mongan, John</name>
      </author>
      <author>
        <name>Nedelec, Pierre</name>
        <uri>https://orcid.org/0000-0002-8535-1541</uri>
      </author>
      <author>
        <name>Nguyen, Uyen</name>
      </author>
      <author>
        <name>Oliva, Sebastian</name>
      </author>
      <author>
        <name>Pease, Matthew W</name>
      </author>
      <author>
        <name>Rastogi, Aditya</name>
      </author>
      <author>
        <name>Sinclair, Jason</name>
      </author>
      <author>
        <name>Smith, Robert X</name>
      </author>
      <author>
        <name>Sugrue, Leo P</name>
      </author>
      <author>
        <name>Thacker, Jonathan</name>
      </author>
      <author>
        <name>Vidic, Igor</name>
      </author>
      <author>
        <name>Villanueva-Meyer, Javier</name>
      </author>
      <author>
        <name>White, Nathan S</name>
      </author>
      <author>
        <name>Aboian, Mariam</name>
      </author>
      <author>
        <name>Conte, Gian Marco</name>
      </author>
      <author>
        <name>Dale, Anders</name>
      </author>
      <author>
        <name>Sabuncu, Mert R</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
      <author>
        <name>Weinberg, Brent</name>
      </author>
      <author>
        <name>Abayazeed, Aly</name>
      </author>
      <author>
        <name>Huang, Raymond</name>
      </author>
      <author>
        <name>Turk, Sevcan</name>
      </author>
      <author>
        <name>Rauschecker, Andreas M</name>
      </author>
      <author>
        <name>Farid, Nikdokht</name>
      </author>
      <author>
        <name>Vollmuth, Philipp</name>
      </author>
      <author>
        <name>Nada, Ayman</name>
      </author>
      <author>
        <name>Bakas, Spyridon</name>
      </author>
      <author>
        <name>Calabrese, Evan</name>
      </author>
      <author>
        <name>Rudie, Jeffrey D</name>
      </author>
    </item>
    <item>
      <title>Rethinking Mitochondria: The Extracellular Dimension</title>
      <link>https://escholarship.org/uc/item/8z28f45q</link>
      <description>Mitochondria are essential organelles that transform the energy contained in metabolic substrates into ATP while supporting numerous cellular processes. Traditionally regarded as strictly intracellular, growing evidence now demonstrates that mitochondria and mitochondria-derived components can also be released into the extracellular space, giving rise to extracellular mitochondria. extracellular mitochondria display remarkable heterogeneity, ranging from intact organelles to individual molecular components, free to vesicle-encapsulated structures, and with functional states spanning from severely damaged to metabolically active. Their release is mediated by tightly regulated mechanisms in both living and dying cells, and is influenced by cellular stress, activation state, and pathways that control mitochondrial selection, compartmentalization, trafficking, and extrusion. Extracellular release fulfills multiple functions across the organism, including quality control, modulation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8z28f45q</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pena-Couso, Laura</name>
      </author>
      <author>
        <name>Makuch, Magdalena</name>
      </author>
      <author>
        <name>Nicolas-Avila, Jose Angel</name>
      </author>
    </item>
    <item>
      <title>Musculoskeletal Imaging</title>
      <link>https://escholarship.org/uc/item/85d2r7cj</link>
      <description>Nuclear medicine and the array of different radiotracers have an important role in the diagnosis and evaluation of a variety of musculoskeletal diseases. Conventional radiography has long been considered the first‐line diagnostic for suspected traumatic fracture. Broadly speaking, stress fractures fall into one of two categories: fractures that arise from normal loading on abnormal bone, termed “insufficiency fractures,” and fractures that arise from abnormal loading on normal bone, termed “fatigue fractures”. Rheumatoid arthritis is an inflammatory disorder with a main target for the synovial membrane of joints, bursae, and tendon sheaths. Radiography is the mainstay in the preliminary evaluation of rheumatoid arthritis. Diabetic patients are at risk for foot infections due to underlying diabetic neuropathy, which leads to a loss of protective sensation and development of anatomic deformities and altered weight‐bearing, and peripheral vascular disease, which limits access of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/85d2r7cj</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Matcuk, George R</name>
      </author>
      <author>
        <name>Gross, Jordan S</name>
      </author>
      <author>
        <name>Patel, Dakshesh B</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Lapalma, Dorian M</name>
      </author>
      <author>
        <name>Stahl, Daniel</name>
      </author>
    </item>
    <item>
      <title>Role of Chest CT in Resource-Driven Healthcare Systems.</title>
      <link>https://escholarship.org/uc/item/7vn2p38r</link>
      <description>Role of Chest CT in Resource-Driven Healthcare Systems.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7vn2p38r</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Quantitative and Qualitative Correlation of 0.55T MRI to CT for Normal Anatomic Structures and Common Pulmonary Pathologies</title>
      <link>https://escholarship.org/uc/item/7px699cx</link>
      <description>Motivation: Although MRI has had low adoption in lung imaging due to susceptibility artifacts, limiting its utility in pulmonary parenchymal imaging, low-field MRI (0.55T) has potential to address those limitations. Goal(s): However, its thoracic diagnostic capabilities remain indeterminate, so our goal was to compare its ability to detect common lung pathologies to chest CT and provide comparable quantitative measurements. Approach: Structures and pathologies were measured with both modalities, and two radiologists identified lung pathologies with MRI only. Results: Results indicated that readers were able to detect pathologies using 0.55T MRI, serving as a first step in exploring 0.55T MRI as an alternative modality. Impact: Our study revealed potential for 0.55T MRI as an emerging tool for MR-based anatomic evaluation of the lung, and its limitations. This can expand lung imaging options and potentially provide better tissue characterization for diagnoses like lung cancer.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7px699cx</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tang, Felicia</name>
      </author>
      <author>
        <name>Chen, Timothy</name>
      </author>
      <author>
        <name>Ebrahimzadeh, Sayedomid</name>
      </author>
      <author>
        <name>Fields, Brandon</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Liu, Jonathan</name>
      </author>
      <author>
        <name>Lee, Yoo Jin</name>
      </author>
      <author>
        <name>Yen, Adam</name>
      </author>
      <author>
        <name>Bowers, Kiara</name>
      </author>
      <author>
        <name>Schonour, Brandon</name>
      </author>
      <author>
        <name>Su, Pan</name>
      </author>
      <author>
        <name>Larson, Peder</name>
      </author>
      <author>
        <name>Yang, Yang</name>
      </author>
      <author>
        <name>Sohn, Jae Ho</name>
        <uri>https://orcid.org/0000-0002-6733-7551</uri>
      </author>
    </item>
    <item>
      <title>Veillonella Bacteremia in Alcoholic Hepatitis</title>
      <link>https://escholarship.org/uc/item/7b06d210</link>
      <description>&lt;i&gt;Veillonella&lt;/i&gt; species are commensal bacteria of the human oral, gut, and vaginal microbiota that are rarely identified as clinically relevant pathogens. Here, we describe a novel case of &lt;i&gt;Veillonella atypica&lt;/i&gt; bacteremia in a patient with biopsy-proven alcoholic hepatitis. &lt;i&gt;Veillonella&lt;/i&gt; species have been correlated with disease severity and hepatic encephalopathy in liver diseases such as autoimmune hepatitis and cirrhosis. Their abundance has also been recently observed to be increased in alcoholic hepatitis, where postinflammatory infections are known to impact mortality. This case report highlights the possible clinical manifestations that result from significant gut dysbiosis in patients with severe alcoholic hepatitis. Early identification and treatment of &lt;i&gt;Veillonella&lt;/i&gt; bacteremia in susceptible populations could be crucial to survival given this organism's predilection for causing life-threatening infections, including meningitis, endocarditis, and osteomyeliti...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7b06d210</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Patrick</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Liang, Tom</name>
      </author>
      <author>
        <name>Dubé, Michael P</name>
      </author>
      <author>
        <name>Politano, Seth</name>
      </author>
    </item>
    <item>
      <title>The Brain Tumor Sequence Registration (BraTS-Reg) Challenge: Establishing Correspondence Between Pre-Operative and Follow-up MRI Scans of Diffuse Glioma Patients</title>
      <link>https://escholarship.org/uc/item/6p30d9pd</link>
      <description>Registration of longitudinal brain MRI scans containing pathologies is challenging due to dramatic changes in tissue appearance. Although there has been progress in developing general-purpose medical image registration techniques, they have not yet attained the requisite precision and reliability for this task, highlighting its inherent complexity. Here we describe the Brain Tumor Sequence Registration (BraTS-Reg) challenge, as the first public benchmark environment for deformable registration algorithms focusing on estimating correspondences between pre-operative and follow-up scans of the same patient diagnosed with a diffuse brain glioma. The BraTS-Reg data comprise de-identified multi-institutional multi-parametric MRI (mpMRI) scans, curated for size and resolution according to a canonical anatomical template, and divided into training, validation, and testing sets. Clinical experts annotated ground truth (GT) landmark points of anatomical locations distinct across the temporal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6p30d9pd</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Baheti, Bhakti</name>
      </author>
      <author>
        <name>Chakrabarty, Satrajit</name>
      </author>
      <author>
        <name>Akbari, Hamed</name>
      </author>
      <author>
        <name>Bilello, Michel</name>
      </author>
      <author>
        <name>Wiestler, Benedikt</name>
      </author>
      <author>
        <name>Schwarting, Julian</name>
      </author>
      <author>
        <name>Calabrese, Evan</name>
      </author>
      <author>
        <name>Rudie, Jeffrey</name>
      </author>
      <author>
        <name>Abidi, Syed</name>
      </author>
      <author>
        <name>Mousa, Mina</name>
      </author>
      <author>
        <name>Villanueva-Meyer, Javier</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Kofler, Florian</name>
      </author>
      <author>
        <name>Shinohara, Russell Takeshi</name>
      </author>
      <author>
        <name>Iglesias, Juan Eugenio</name>
      </author>
      <author>
        <name>Mok, Tony CW</name>
      </author>
      <author>
        <name>Chung, Albert CS</name>
      </author>
      <author>
        <name>Wodzinski, Marek</name>
      </author>
      <author>
        <name>Jurgas, Artur</name>
      </author>
      <author>
        <name>Marini, Niccolo</name>
      </author>
      <author>
        <name>Atzori, Manfredo</name>
      </author>
      <author>
        <name>Muller, Henning</name>
      </author>
      <author>
        <name>Grobroehmer, Christoph</name>
      </author>
      <author>
        <name>Siebert, Hanna</name>
      </author>
      <author>
        <name>Hansen, Lasse</name>
      </author>
      <author>
        <name>Heinrich, Mattias P</name>
      </author>
      <author>
        <name>Canalini, Luca</name>
      </author>
      <author>
        <name>Klein, Jan</name>
      </author>
      <author>
        <name>Gerken, Annika</name>
      </author>
      <author>
        <name>Heldmann, Stefan</name>
      </author>
      <author>
        <name>Hering, Alessa</name>
      </author>
      <author>
        <name>Hahn, Horst K</name>
      </author>
      <author>
        <name>Meng, Mingyuan</name>
      </author>
      <author>
        <name>Bi, Lei</name>
      </author>
      <author>
        <name>Feng, Dagan</name>
      </author>
      <author>
        <name>Kim, Jinman</name>
      </author>
      <author>
        <name>Zeineldin, Ramy A</name>
      </author>
      <author>
        <name>Karar, Mohamed E</name>
      </author>
      <author>
        <name>Mathis-Ullrich, Franziska</name>
      </author>
      <author>
        <name>Burgert, Oliver</name>
      </author>
      <author>
        <name>Abderezaei, Javid</name>
      </author>
      <author>
        <name>Pionteck, Aymeric</name>
      </author>
      <author>
        <name>Chopra, Agamdeep</name>
      </author>
      <author>
        <name>Kurt, Mehmet</name>
      </author>
      <author>
        <name>Yan, Kewei</name>
      </author>
      <author>
        <name>Yan, Yonghong</name>
      </author>
      <author>
        <name>Tang, Zhe</name>
      </author>
      <author>
        <name>Ma, Jianqiang</name>
      </author>
      <author>
        <name>Nasser, Sahar Almahfouz</name>
      </author>
      <author>
        <name>Kurian, Nikhil Cherian</name>
      </author>
      <author>
        <name>Meena, Mohit</name>
      </author>
      <author>
        <name>Shamsi, Saqib</name>
      </author>
      <author>
        <name>Sethi, Amit</name>
      </author>
      <author>
        <name>Tustison, Nicholas J</name>
      </author>
      <author>
        <name>Avants, Brian B</name>
      </author>
      <author>
        <name>Cook, Philip</name>
      </author>
      <author>
        <name>Gee, James C</name>
      </author>
      <author>
        <name>Tian, Lin</name>
      </author>
      <author>
        <name>Greer, Hastings</name>
      </author>
      <author>
        <name>Niethammer, Marc</name>
      </author>
      <author>
        <name>Hoopes, Andrew</name>
      </author>
      <author>
        <name>Hoffmann, Malte</name>
      </author>
      <author>
        <name>Dalca, Adrian V</name>
      </author>
      <author>
        <name>Christodoulidis, Stergios</name>
      </author>
      <author>
        <name>Estiene, Theo</name>
      </author>
      <author>
        <name>Vakalopoulou, Maria</name>
      </author>
      <author>
        <name>Paragios, Nikos</name>
      </author>
      <author>
        <name>Marcus, Daniel S</name>
      </author>
      <author>
        <name>Davatzikos, Christos</name>
      </author>
      <author>
        <name>Sotiras, Aristeidis</name>
      </author>
      <author>
        <name>Menze, Bjoern</name>
      </author>
      <author>
        <name>Bakas, Spyridon</name>
      </author>
      <author>
        <name>Waldmannstetter, Diana</name>
      </author>
    </item>
    <item>
      <title>Radiomics Analysis for Predicting Growth of Subsolid Lung Nodules on CT</title>
      <link>https://escholarship.org/uc/item/5c97k07d</link>
      <description>Abstract  Background Accurate identification of growing subsolid nodules is crucial for effective risk stratification and the early detection of invasive lung cancer, allowing for timely treatment while avoiding unnecessary surgery on low-risk nodules that would otherwise remain stable. The traditional method of risk stratification, which relies on qualitative visual analysis of CT scans, remains challenging. Therefore, this study aims to leverage a longitudinal dataset of subsolid nodules on CT and develop radiomic and clinical feature-based models to identify nodules that are likely to grow over time.   Purpose The purpose of this study is to develop a machine learning model to predict the growth of subsolid nodules using a combination of radiomic and clinical features.   Materials and Methods A retrospective study was conducted on a cohort of patients who had undergone chest CT scans at a single institution between 2015 and 2019. Corresponding radiology reports were used to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5c97k07d</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Weng, Shiny</name>
      </author>
      <author>
        <name>Bondarenko, Masha</name>
      </author>
      <author>
        <name>Chaudhari, Gunvant</name>
      </author>
      <author>
        <name>Innaje, Arun</name>
      </author>
      <author>
        <name>Chen, Terrence</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Sohn, Jae Ho</name>
        <uri>https://orcid.org/0000-0002-6733-7551</uri>
      </author>
    </item>
    <item>
      <title>Compressed Sensing MR Imaging (CS-MRI) of the Knee: Assessment of Quality, Inter-reader Agreement, and Acquisition Time</title>
      <link>https://escholarship.org/uc/item/59v5c79r</link>
      <description>We compared 3 Tesla (3T) compressed sensing (CS)-MRI of different pulse sequences with various acceleration factors to standard fast spin-echo (FSE) sequences in terms of time, quality, and inter-reader agreement. Each sequence was qualitatively ranked and then qualitatively scored for blurring, artifact, low contrast detection, noise pattern, signal-to-noise ratio, and overall quality. The CS-MRI sequences demonstrated very good overall quality compared with routine FSE sequences with overall good inter-reader agreement.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/59v5c79r</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Matcuk, George R</name>
      </author>
      <author>
        <name>Gross, Jordan S</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Cen, Steven</name>
      </author>
    </item>
    <item>
      <title>Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome</title>
      <link>https://escholarship.org/uc/item/54t4p8m2</link>
      <description>Collagen type IV alpha 1 and alpha 2 (COL4A1 and COL4A2) are major components of almost all basement membranes. COL4A1 and COL4A2 mutations cause a multisystem disorder that can affect any organ but typically involves the cerebral vasculature, eyes, kidneys and skeletal muscles. In recent years, patient advocacy and family support groups have united under the name of Gould syndrome. The manifestations of Gould syndrome are highly variable, and animal studies suggest that allelic heterogeneity and genetic context contribute to the clinical variability. We previously characterized a mouse model of Gould syndrome caused by a Col4a1 mutation in which the severities of ocular anterior segment dysgenesis (ASD), myopathy and intracerebral hemorrhage (ICH) were dependent on genetic background. Here, we performed a genetic modifier screen to provide insight into the mechanisms contributing to Gould syndrome pathogenesis and identified a single locus [modifier of Gould syndrome 1 (MoGS1)]...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/54t4p8m2</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mao, Mao</name>
      </author>
      <author>
        <name>Popli, Tanav</name>
      </author>
      <author>
        <name>Jeanne, Marion</name>
      </author>
      <author>
        <name>Hoff, Kendall</name>
      </author>
      <author>
        <name>Sen, Saunak</name>
      </author>
      <author>
        <name>Gould, Douglas B</name>
        <uri>https://orcid.org/0000-0001-5127-5328</uri>
      </author>
    </item>
    <item>
      <title>The SNO+ experiment</title>
      <link>https://escholarship.org/uc/item/4xb45973</link>
      <description>The SNO+ experiment is located 2 km underground at SNOLAB in Sudbury, Canada. A low background search for neutrinoless double beta (0νββ) decay will be conducted using 780 tonnes of liquid scintillator loaded with 3.9 tonnes of natural tellurium, corresponding to 1.3 tonnes of 130Te. This paper provides a general overview of the SNO+ experiment, including detector design, construction of process plants, commissioning efforts, electronics upgrades, data acquisition systems, and calibration techniques. The SNO+ collaboration is reusing the acrylic vessel, PMT array, and electronics of the SNO detector, having made a number of experimental upgrades and essential adaptations for use with the liquid scintillator. With low backgrounds and a low energy threshold, the SNO+ collaboration will also pursue a rich physics program beyond the search for 0νββ decay, including studies of geo- and reactor antineutrinos, supernova and solar neutrinos, and exotic physics such as the search for invisible...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4xb45973</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Albanese, V</name>
      </author>
      <author>
        <name>Alves, R</name>
      </author>
      <author>
        <name>Anderson, MR</name>
      </author>
      <author>
        <name>Andringa, S</name>
      </author>
      <author>
        <name>Anselmo, L</name>
      </author>
      <author>
        <name>Arushanova, E</name>
      </author>
      <author>
        <name>Asahi, S</name>
      </author>
      <author>
        <name>Askins, M</name>
      </author>
      <author>
        <name>Auty, DJ</name>
      </author>
      <author>
        <name>Back, AR</name>
      </author>
      <author>
        <name>Back, S</name>
      </author>
      <author>
        <name>Barão, F</name>
      </author>
      <author>
        <name>Barnard, Z</name>
      </author>
      <author>
        <name>Barr, A</name>
      </author>
      <author>
        <name>Barros, N</name>
      </author>
      <author>
        <name>Bartlett, D</name>
      </author>
      <author>
        <name>Bayes, R</name>
      </author>
      <author>
        <name>Beaudoin, C</name>
      </author>
      <author>
        <name>Beier, EW</name>
      </author>
      <author>
        <name>Berardi, G</name>
      </author>
      <author>
        <name>Bialek, A</name>
      </author>
      <author>
        <name>Biller, SD</name>
      </author>
      <author>
        <name>Blucher, E</name>
      </author>
      <author>
        <name>Bonventre, R</name>
      </author>
      <author>
        <name>Boulay, M</name>
      </author>
      <author>
        <name>Braid, D</name>
      </author>
      <author>
        <name>Caden, E</name>
      </author>
      <author>
        <name>Callaghan, EJ</name>
      </author>
      <author>
        <name>Caravaca, J</name>
      </author>
      <author>
        <name>Carvalho, J</name>
      </author>
      <author>
        <name>Cavalli, L</name>
      </author>
      <author>
        <name>Chauhan, D</name>
      </author>
      <author>
        <name>Chen, M</name>
      </author>
      <author>
        <name>Chkvorets, O</name>
      </author>
      <author>
        <name>Clark, KJ</name>
      </author>
      <author>
        <name>Cleveland, B</name>
      </author>
      <author>
        <name>Connors, C</name>
      </author>
      <author>
        <name>Cookman, D</name>
        <uri>https://orcid.org/0000-0001-9385-1194</uri>
      </author>
      <author>
        <name>Coulter, IT</name>
      </author>
      <author>
        <name>Cox, MA</name>
      </author>
      <author>
        <name>Cressy, D</name>
      </author>
      <author>
        <name>Dai, X</name>
      </author>
      <author>
        <name>Darrach, C</name>
      </author>
      <author>
        <name>Davis-Purcell, B</name>
      </author>
      <author>
        <name>Deluce, C</name>
      </author>
      <author>
        <name>Depatie, MM</name>
      </author>
      <author>
        <name>Descamps, F</name>
      </author>
      <author>
        <name>Di Lodovico, F</name>
      </author>
      <author>
        <name>Dittmer, J</name>
      </author>
      <author>
        <name>Doxtator, A</name>
      </author>
      <author>
        <name>Duhaime, N</name>
      </author>
      <author>
        <name>Duncan, F</name>
      </author>
      <author>
        <name>Dunger, J</name>
      </author>
      <author>
        <name>Earle, AD</name>
      </author>
      <author>
        <name>Fabris, D</name>
      </author>
      <author>
        <name>Falk, E</name>
      </author>
      <author>
        <name>Farrugia, A</name>
      </author>
      <author>
        <name>Fatemighomi, N</name>
      </author>
      <author>
        <name>Felber, C</name>
      </author>
      <author>
        <name>Fischer, V</name>
      </author>
      <author>
        <name>Fletcher, E</name>
      </author>
      <author>
        <name>Ford, R</name>
      </author>
      <author>
        <name>Frankiewicz, K</name>
      </author>
      <author>
        <name>Gagnon, N</name>
      </author>
      <author>
        <name>Gaur, A</name>
      </author>
      <author>
        <name>Gauthier, J</name>
      </author>
      <author>
        <name>Gibson-Foster, A</name>
      </author>
      <author>
        <name>Gilje, K</name>
      </author>
      <author>
        <name>González-Reina, OI</name>
      </author>
      <author>
        <name>Gooding, D</name>
      </author>
      <author>
        <name>Gorel, P</name>
      </author>
      <author>
        <name>Graham, K</name>
      </author>
      <author>
        <name>Grant, C</name>
      </author>
      <author>
        <name>Grove, J</name>
      </author>
      <author>
        <name>Grullon, S</name>
      </author>
      <author>
        <name>Guillian, E</name>
      </author>
      <author>
        <name>Hall, S</name>
      </author>
      <author>
        <name>Hallin, AL</name>
      </author>
      <author>
        <name>Hallman, D</name>
      </author>
      <author>
        <name>Hans, S</name>
      </author>
      <author>
        <name>Hartnell, J</name>
      </author>
      <author>
        <name>Harvey, P</name>
      </author>
      <author>
        <name>Hedayatipour, M</name>
      </author>
      <author>
        <name>Heintzelman, WJ</name>
      </author>
      <author>
        <name>Heise, J</name>
      </author>
      <author>
        <name>Helmer, RL</name>
      </author>
      <author>
        <name>Hodak, B</name>
      </author>
      <author>
        <name>Hodak, M</name>
      </author>
      <author>
        <name>Hood, M</name>
      </author>
      <author>
        <name>Horne, D</name>
      </author>
      <author>
        <name>Hreljac, B</name>
      </author>
      <author>
        <name>Hu, J</name>
      </author>
      <author>
        <name>Hussain, SMA</name>
      </author>
      <author>
        <name>Iida, T</name>
      </author>
      <author>
        <name>Inácio, AS</name>
      </author>
      <author>
        <name>Jackson, CM</name>
      </author>
      <author>
        <name>Jelley, NA</name>
      </author>
      <author>
        <name>Jillings, CJ</name>
      </author>
      <author>
        <name>Jones, C</name>
      </author>
      <author>
        <name>Jones, PG</name>
      </author>
    </item>
    <item>
      <title>Risk factors for immune checkpoint inhibitor colitis: a retrospective multi-center cohort study using electronic health records</title>
      <link>https://escholarship.org/uc/item/4vb921t9</link>
      <description>BackgroundImmune checkpoint inhibitors (ICIs) are effective for many cancers but often cause immune-related adverse events, particularly gastrointestinal (GI) complications such as colitis. Identifying risk factors for ICI colitis (CIC) could improve patient selection and discover potential mechanisms relevant to idiopathic inflammatory bowel disease (IBD). We aim to identify risk factors with a robust methodological approach in a large multi-center longitudinal cohort.MethodsWe used electronic health record data from six University of California institutions with 10,260 adults on ICIs. Baseline and time-varying predictors were defined based on prior IBD epidemiology studies, including interactions. LASSO Cox regression was applied to data from UCSF Central Data Warehouse to select the most predictive model, with coefficients estimated using multi-center data.Results and conclusionFourteen significant predictors of CIC were identified. The strongest predictors were concurrent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4vb921t9</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chu, Danny Hoi Tsun</name>
      </author>
      <author>
        <name>Schalkamp, Ann-Kathrin</name>
        <uri>https://orcid.org/0000-0002-8609-9165</uri>
      </author>
      <author>
        <name>Rudrapatna, Vivek A</name>
      </author>
    </item>
    <item>
      <title>Imaging Approach to Pediatric and Adolescent Familial Cancer Syndromes</title>
      <link>https://escholarship.org/uc/item/4md107vr</link>
      <description>Recent advances in our understanding of the genetic and pathophysiologic mechanism of human malignancies have led to the recognition of frequent hereditary basis of many cancers. Hereditary cancer syndromes, which are now believed to cause up to 5% of human malignancies, are characterized by the early onset of various, multifocal, often advanced malignancies of usually more than one organ system. Frequently, multiple family members are involved. These hereditary cancer syndromes may pose specific diagnostic and therapeutic challenges, as they warrant contemporary paradigms for their screening protocols and targeted therapies. Here, we review imaging approaches to the most common hereditary cancer syndromes, including multiple endocrine neoplasia (MEN) syndromes, von Hippel-Lindau (VHL) syndrome, and Li-Fraumeni cancer syndrome.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4md107vr</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Ahmadzadehfar, Hojjat</name>
      </author>
      <author>
        <name>Yordanova, Anna</name>
      </author>
      <author>
        <name>Nabipour, Iraj</name>
      </author>
      <author>
        <name>Jokar, Narges</name>
      </author>
      <author>
        <name>Assadi, Majid</name>
      </author>
      <author>
        <name>Joyce, Peter</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Comment on “Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease”</title>
      <link>https://escholarship.org/uc/item/48j8p9kk</link>
      <description>Comment on “Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease”</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/48j8p9kk</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Schalkamp, Ann‐Kathrin</name>
      </author>
      <author>
        <name>Peall, Kathryn J</name>
      </author>
      <author>
        <name>Harrison, Neil A</name>
      </author>
      <author>
        <name>Sandor, Cynthia</name>
      </author>
    </item>
    <item>
      <title>Voltage-gated potassium channels (Kv) in GtoPdb v.2025.4</title>
      <link>https://escholarship.org/uc/item/2mj7k3h5</link>
      <description>The 6TM family of K channels comprises the voltage-gated KV subfamilies, the EAG subfamily (which includes hERG channels), the Ca2+-activated Slo subfamily (actually with 7TM, termed BK) and the Ca2+-activated SK subfamily. These channels possess a pore-forming α subunit that comprises tetramers of identical subunits (homomeric) or of different subunits (heteromeric). Heteromeric channels can only be formed within subfamilies (e.g. Kv1.1 with Kv1.2; Kv7.2 with Kv7.3). The pharmacology largely reflects the subunit composition of the functional channel.Kv7 channelsKv7.1-Kv7.5 (KCNQ1-5) K+ channels are voltage-gated K+ channels with major roles in neurons, muscle cells and epithelia where they underlie physiologically important K+ currents, such as the neuronal M-current and the cardiac IKs. Genetic deficiencies in all five KCNQ genes result in human excitability disorders, including epilepsy, autism spectrum disorders, cardiac arrhythmias and deafness. Thanks to the recent knowledge...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2mj7k3h5</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Attali, Bernard</name>
      </author>
      <author>
        <name>Trimmer, James S</name>
      </author>
      <author>
        <name>Stühmer, Walter</name>
      </author>
      <author>
        <name>Sanguinetti, Michael C</name>
      </author>
      <author>
        <name>Rudy, Bernardo</name>
      </author>
      <author>
        <name>Robertson, Gail A</name>
      </author>
      <author>
        <name>Pardo, Luis A</name>
      </author>
      <author>
        <name>Nerbonne, Jeanne</name>
      </author>
      <author>
        <name>Mckinnon, David</name>
      </author>
      <author>
        <name>Lazdunski, Michel</name>
      </author>
      <author>
        <name>Jan, Lily Y</name>
      </author>
      <author>
        <name>Gutman, George A</name>
      </author>
      <author>
        <name>Grissmer, Stephan</name>
      </author>
      <author>
        <name>Giese, M Hunter</name>
      </author>
      <author>
        <name>Chandy, K George</name>
      </author>
      <author>
        <name>Wang, Xiaoliang</name>
      </author>
    </item>
    <item>
      <title>Imaging of COVID-19: CT, MRI, and PET</title>
      <link>https://escholarship.org/uc/item/2k41x0t2</link>
      <description>Soon after reports of a novel coronavirus capable of causing severe pneumonia surfaced in late 2019, expeditious global spread of the Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) forced the World Health Organization to declare an international state of emergency. Although best known for causing symptoms of upper respiratory tract infection in mild cases and fulminant pneumonia in severe disease, Coronavirus Disease 2019 (COVID-19) has also been associated with gastrointestinal, neurologic, cardiac, and hematologic presentations. Despite concerns over poor specificity and undue radiation exposure, chest imaging nonetheless remains central to the initial diagnosis and monitoring of COVID-19 progression, as well as to the evaluation of complications. Classic features on chest CT include ground-glass and reticular opacities with or without superimposed consolidations, frequently presenting in a bilateral, peripheral, and posterior distribution. More recently,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2k41x0t2</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Dadgar, Habibollah</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients</title>
      <link>https://escholarship.org/uc/item/1w06h4wd</link>
      <description>PURPOSE: Our purpose was to conduct a comprehensive systematic review of all existing literature regarding imaging findings on chest CT and associated clinical features in pregnant patients diagnosed with COVID-19.
MATERIALS &amp;amp; METHODS: A literature search was conducted on April 21, 2020 and updated on July 24, 2020 using PubMed, Embase, World Health Organization, and Google Scholar databases. Only studies which described chest CT findings of COVID-19 in pregnant patients were included for analysis.
RESULTS: A total of 67 articles and 427 pregnant patients diagnosed with COVID-19 were analyzed. The most frequently encountered pulmonary findings on chest CT were ground-glass opacities (77.2%, 250/324), posterior lung involvement (72.5%, 50/69), multilobar involvement (71.8%, 239/333), bilateral lung involvement (69.4%, 231/333), peripheral distribution (68.1%, 98/144), and consolidation (40.9%, 94/230). Pregnant patients were also found to present more frequently with consolidation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1w06h4wd</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Oshay, Rachel R</name>
      </author>
      <author>
        <name>Chen, Michael YC</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Lee, Ryan S</name>
      </author>
      <author>
        <name>Mosallaei, Daniel</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Coronavirus disease 2019 (COVID-19) pandemic: Review of guidelines for resuming non-urgent imaging and procedures in radiology during Phase II</title>
      <link>https://escholarship.org/uc/item/1kg6057p</link>
      <description>Since the spread of the coronavirus disease 2019 (COVID-19) was designated as a pandemic by the World Health Organization, health care systems have been forced to adapt rapidly to defer less urgent care during the crisis. The United States (U.S.) has adopted a four-phase approach to decreasing and then resuming non-essential work. Through strong restrictive measures, Phase I slowed the spread of disease, allowing states to safely diagnose, isolate, and treat patients with COVID-19. In support of social distancing measures, non-urgent studies were postponed, and this created a backlog. Now, as states transition to Phase II, restrictions on non-essential activities will ease, and radiology departments must re-establish care while continuing to mitigate the risk of COVID-19 transmission all while accommodating this backlog. In this article, we propose a roadmap that incorporates the current practice guidelines and subject matter consensus statements for the phased reopening of non-urgent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1kg6057p</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Azam, Saif A</name>
      </author>
      <author>
        <name>Myers, Lee</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Patel, Dakshesh</name>
      </author>
      <author>
        <name>Roberge, Eric</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
      <author>
        <name>Reddy, Sravanthi</name>
      </author>
    </item>
    <item>
      <title>PREDICTORS FOR PATIENTS UNDERSTANDING REASON FOR HOSPITALIZATION</title>
      <link>https://escholarship.org/uc/item/0sc932x7</link>
      <description>PREDICTORS FOR PATIENTS UNDERSTANDING REASON FOR HOSPITALIZATION</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0sc932x7</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Weerahandi, Himali</name>
      </author>
      <author>
        <name>Ziaeian, Boback</name>
        <uri>https://orcid.org/0000-0001-9787-3649</uri>
      </author>
      <author>
        <name>Fogerty, Robert L</name>
      </author>
      <author>
        <name>Horwitz, Leora I</name>
      </author>
    </item>
    <item>
      <title>Latent Tuberculosis Infection Care Cascade Outcomes in Primary Care Clinics in the Tuberculosis Epidemiologic Studies Consortium-III</title>
      <link>https://escholarship.org/uc/item/0kz016wt</link>
      <description>Purpose Tuberculosis (TB) was the leading infectious cause of death worldwide in 2023. U.S. tuberculosis (TB) cases mostly result from reactivation of latent TB infection (LTBI). LTBI treatment is about 90% effective in preventing TB disease; thus, screening and treatment are essential for U.S. TB elimination efforts. Persons at higher risk of infection seek care at primary care clinics, which represent a critical setting for scaling up TB testing and LTBI treatment. Methods Using longitudinal electronic health record (EHR) data, we described a comprehensive LTBI care cascade among individuals at higher risk of infection seeking care in U.S. primary care clinics – from identification of higher-risk persons through testing, diagnosis, and treatment. Results Among 3.5 million patients, 48% were determined to be at higher risk; 86% were not tested. Among those tested, there was a 17% test positivity rate. Only 61% of persons diagnosed with LTBI were prescribed treatment; 44% did...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kz016wt</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Vonnahme, Laura A</name>
      </author>
      <author>
        <name>Ravindhran, Preeti</name>
      </author>
      <author>
        <name>Espey, Julie</name>
      </author>
      <author>
        <name>Sharma, Bhumika</name>
      </author>
      <author>
        <name>Moore, Taylor</name>
      </author>
      <author>
        <name>Aiona, Kaylynn</name>
      </author>
      <author>
        <name>Skarbinski, Jacek</name>
      </author>
      <author>
        <name>Narita, Masahiro</name>
      </author>
      <author>
        <name>Shete, Priya B</name>
      </author>
      <author>
        <name>Adhimurthy, Jagadheeswari</name>
      </author>
      <author>
        <name>Broadhurst, Richard</name>
      </author>
      <author>
        <name>Wada, Paul</name>
      </author>
      <author>
        <name>Bond, Grace</name>
      </author>
      <author>
        <name>Murrill, Matthew T</name>
        <uri>https://orcid.org/0000-0001-7567-7727</uri>
      </author>
      <author>
        <name>Huang, Kuan-Chieh</name>
      </author>
      <author>
        <name>Lee, Meagan</name>
      </author>
      <author>
        <name>Lin, Jihming</name>
      </author>
      <author>
        <name>Winglee, Kathryn</name>
      </author>
      <author>
        <name>Consortium, for the Tuberculosis Epidemiologic Studies</name>
      </author>
    </item>
    <item>
      <title>MicroRNA-19b Associates with Ago2 in the Amygdala Following Chronic Stress and Regulates the Adrenergic Receptor Beta 1</title>
      <link>https://escholarship.org/uc/item/09g0p84p</link>
      <description>Activation of the stress response in the presence of diverse challenges requires numerous adaptive molecular and cellular changes. To identify specific microRNA molecules that are altered following chronic stress, mice were subjected to the chronic social defeat procedure. The amygdala from these mice was collected and a screen for microRNAs that were recruited to the RNA-induced silencing complex and differentially expressed between the stressed and unstressed mice was conducted. One of the microRNAs that were significantly altered was microRNA-19b (miR-19b). Bioinformatics analysis revealed the adrenergic receptor β-1 (Adrb1) as a potential target for this microRNA with multiple conserved seed sites. Consistent with its putative regulation by miR-19b, Adrb1 levels were reduced in the basolateral amygdala (BLA) following chronic stress. In vitro studies using luciferase assays showed a direct effect of miR-19b on Adrb1 levels, which were not evident when miR-19b seed sequences...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/09g0p84p</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Volk, Naama</name>
      </author>
      <author>
        <name>Paul, Evan D</name>
      </author>
      <author>
        <name>Haramati, Sharon</name>
      </author>
      <author>
        <name>Eitan, Chen</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Zwang, Raaya</name>
      </author>
      <author>
        <name>Gil, Shosh</name>
      </author>
      <author>
        <name>Lowry, Christopher A</name>
      </author>
      <author>
        <name>Chen, Alon</name>
      </author>
    </item>
    <item>
      <title>Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis</title>
      <link>https://escholarship.org/uc/item/017771km</link>
      <description>BACKGROUND: Tuberculosis affects over a million children annually. Ethambutol (EMB) is a key component of the standard four-drug therapy for drug-susceptible tuberculosis in children, yet comprehensive pharmacokinetic studies have been lacking. We characterized the population pharmacokinetics of EMB through an individual patient data meta-analysis to determine optimal dosing strategies.
METHODS: EMB concentrations and individual-level patient data from three studies were analyzed using nonlinear mixed effects modeling. Simulations compared current World Health Organization (WHO)-recommended doses and model-informed optimized doses. Target exposure distribution (AUC 13.8-17.7 mg·h/L), which had been previously established in adult clinical trials, guided dose optimization.
RESULTS: A total of 220 participants, aged from 0.2 to 15 years and weighing between 3.6 and 43.0 kg, contributed 1,085 plasma concentrations of EMB for model development. The effect of weight was incorporated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/017771km</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chung, Tae Kyu</name>
      </author>
      <author>
        <name>Yang, Eunsol</name>
      </author>
      <author>
        <name>Shin, Maureen</name>
      </author>
      <author>
        <name>Solans, Belen P</name>
      </author>
      <author>
        <name>Zhou, Xujia</name>
      </author>
      <author>
        <name>Hwang, Sejung</name>
      </author>
      <author>
        <name>Yoon, Michael C</name>
        <uri>https://orcid.org/0000-0002-2900-5257</uri>
      </author>
      <author>
        <name>Purohit, Dvijen</name>
      </author>
      <author>
        <name>Yang, Dongsheng</name>
      </author>
      <author>
        <name>Mouksassi, Samer</name>
      </author>
      <author>
        <name>Béranger, Agathe</name>
      </author>
      <author>
        <name>Bekker, Adrie</name>
      </author>
      <author>
        <name>Kwara, Awewura</name>
      </author>
      <author>
        <name>Panjasawatwong, Navarat</name>
      </author>
      <author>
        <name>Savic, Radojka M</name>
      </author>
    </item>
    <item>
      <title>NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE</title>
      <link>https://escholarship.org/uc/item/6pz2n28b</link>
      <description>With the recent approval of &lt;sup&gt;177&lt;/sup&gt;Lu-DOTATATE for use in gastroenteropancreatic neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing. Representatives from the North American Neuroendocrine Tumor Society and the Society of Nuclear Medicine and Molecular Imaging collaborated to develop a practical consensus guideline for the administration of &lt;sup&gt;177&lt;/sup&gt;Lu-DOTATATE. In this paper, we discuss patient screening, maintenance somatostatin analog therapy requirements, treatment location and room preparation, drug administration, and patient release as well as strategies for radiation safety, toxicity monitoring, management of potential complications, and follow-up. Controversies regarding the role of radiation dosimetry are discussed as well. This document is designed to provide practical guidance on how to safely treat patients with this therapy.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6pz2n28b</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Hope, Thomas A</name>
      </author>
      <author>
        <name>Abbott, Amanda</name>
      </author>
      <author>
        <name>Colucci, Karen</name>
      </author>
      <author>
        <name>Bushnell, David L</name>
      </author>
      <author>
        <name>Gardner, Linda</name>
      </author>
      <author>
        <name>Graham, William S</name>
      </author>
      <author>
        <name>Lindsay, Sheila</name>
      </author>
      <author>
        <name>Metz, David C</name>
      </author>
      <author>
        <name>Pryma, Daniel A</name>
      </author>
      <author>
        <name>Stabin, Michael G</name>
      </author>
      <author>
        <name>Strosberg, Jonathan R</name>
      </author>
    </item>
    <item>
      <title>Muscle mass, function and performance across the adult lifespan: the study of muscle, mobility and ageing</title>
      <link>https://escholarship.org/uc/item/6d4540x4</link>
      <description>BACKGROUND: D3-creatine (D3Cr) dilution provides an accurate estimate of total body skeletal muscle mass, yet few studies have examined its relationship with function and performance across the lifespan, particularly before age 70. We modelled the association of age with D₃Cr muscle mass across adulthood and compared it with age-related differences in muscle function and performance.
METHODS: Adults aged 30-69&amp;nbsp;years (n = 69; 33 men) and 70+ (n = 826; 344 men) from the Study of Muscle, Mobility and Ageing completed assessments of D3Cr muscle mass, magnetic resonance imaging (MRI) thigh muscle volume, 1-RM leg strength and leg extension power, 4&amp;nbsp;m walking speed and cardiorespiratory fitness (VO2 peak). Regression models estimated annualised percent differences with age for each outcome.
RESULTS: In men, progressively lower D₃Cr muscle mass with advancing age (-0.5%/year in young adults to -1.4%/year in oldest-old) paralleled the pattern observed for leg strength and walking...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6d4540x4</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Hetherington-Rauth, Megan</name>
      </author>
      <author>
        <name>McCulloch, Charles E</name>
        <uri>https://orcid.org/0000-0002-1279-6179</uri>
      </author>
      <author>
        <name>Kritchevsky, Stephen B</name>
      </author>
      <author>
        <name>Newman, Anne B</name>
      </author>
      <author>
        <name>Hepple, Russel T</name>
      </author>
      <author>
        <name>Coen, Paul M</name>
      </author>
      <author>
        <name>Goodpaster, Bret H</name>
      </author>
      <author>
        <name>Shankaran, Mahalakshmi</name>
      </author>
      <author>
        <name>Hellerstein, Marc</name>
      </author>
      <author>
        <name>Evans, William J</name>
      </author>
      <author>
        <name>Toledo, Frederico GS</name>
      </author>
      <author>
        <name>Lane, Nancy E</name>
      </author>
      <author>
        <name>Cawthon, Peggy M</name>
      </author>
    </item>
    <item>
      <title>In Response to Chad Kollas Reply “Right Assessment, Wrong Conclusion”</title>
      <link>https://escholarship.org/uc/item/5wf436c6</link>
      <description>In Response to Chad Kollas Reply “Right Assessment, Wrong Conclusion”</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5wf436c6</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kabella, Dan</name>
      </author>
    </item>
    <item>
      <title>Polycyclic aromatic hydrocarbons and cannabinoids in secondhand cannabis smoke</title>
      <link>https://escholarship.org/uc/item/1377z8n0</link>
      <description>The legalization of cannabis is exposing more people to secondhand smoke (SHS) generated during cannabis use. Given the serious health effects caused by tobacco SHS, there is a need to assess the potential health effects of exposure to cannabis SHS. As a step toward this, we measured the concentrations of cannabinoids, nicotine and polycyclic aromatic hydrocarbons (PAHs) in air samples collected in public places where cannabis was being consumed. These were compared with concentrations in exhaled aerosols from cannabis smoking and vaping, and in tobacco SHS. Tetrahydrocannabinol concentrations were 22 to 255 µg/m3 in field samples, below the threshold for psychoactive effects. Nicotine concentrations in field samples did not exceed 1 µg/m3. The total PAH concentrations in field samples were from 3.2 to 80.5 ng/m3, depending on location type. By contrast, PAH levels averaged 72 ng/m3 in tobacco SHS and 220 ng/m3 in the more concentrated, exhaled cannabis aerosols. A total of 22...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1377z8n0</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Tang, Xiaochen</name>
        <uri>https://orcid.org/0000-0003-4168-9871</uri>
      </author>
      <author>
        <name>Huang, Abel S</name>
      </author>
      <author>
        <name>Russell, Marion L</name>
        <uri>https://orcid.org/0000-0002-7723-6746</uri>
      </author>
      <author>
        <name>St. Helen, Gideon</name>
      </author>
      <author>
        <name>Jacob, Peyton</name>
      </author>
      <author>
        <name>Destaillats, Hugo</name>
      </author>
      <author>
        <name>Schick, Suzaynn F</name>
        <uri>https://orcid.org/0000-0001-7101-3077</uri>
      </author>
    </item>
    <item>
      <title>Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study.</title>
      <link>https://escholarship.org/uc/item/05s6q69b</link>
      <description>&lt;h4&gt;Objective&lt;/h4&gt;To assess whether biologics (dupilumab, mepolizumab, and omalizumab) used for conditions other than chronic rhinosinusitis with nasal polyps (CRSwNP) reduce the frequency of acute bacterial rhinosinusitis (ABRS) episodes.&lt;h4&gt;Methods&lt;/h4&gt;This retrospective cohort study utilized the All of Us Research Program database to identify patients treated with dupilumab, mepolizumab, or omalizumab, excluding those with CRSwNP. A control group matched by race, gender, and comorbidities (asthma, allergic rhinitis, atopic dermatitis, smoking status) was created using propensity score matching (1:1 ratio) and K-nearest neighbors. The primary outcome was the frequency of ABRS episodes in biologic-exposed versus control groups, analyzed using χ&lt;sup&gt;2&lt;/sup&gt; tests to calculate odds ratios (ORs) and 95% confidence intervals (CIs).&lt;h4&gt;Results&lt;/h4&gt;Out of 2094 subjects, the biologic group had a significantly lower ABRS rate (6%) compared to controls (14%) (OR 0.4349, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001)....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/05s6q69b</guid>
      <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Zheng, Wynne</name>
      </author>
      <author>
        <name>Arslan, Maeen</name>
      </author>
      <author>
        <name>Zhu, Christina</name>
      </author>
      <author>
        <name>Guirguis, Christopher</name>
      </author>
      <author>
        <name>Spielman, Daniel</name>
      </author>
    </item>
    <item>
      <title>Precision Labeling of Native Antibodies with Lock Coupling</title>
      <link>https://escholarship.org/uc/item/6k82t8tp</link>
      <description>The formation of stable protein complexes enables much of biotechnology, but even high-affinity complexes can dissociate, limiting potential applications in biomaterials, bioimaging, nanomedicine, and other protein-based technologies. Here, we describe lock coupling, a simple and selective one-step reaction between interfacial lysine and glutamate or aspartate side chains to form stable isopeptide bonds and be used for the precise labeling of native antibodies. We identify conditions in which short-lived activated esters formed by the aqueous carbodiimide EDC promote isopeptide bond formation specifically at preassociated amine-acid pairs. Indiscriminate cross-linking is minimized by formation of protein complexes before addition of catalyst, use of acidic pH to suppress exposed Lys reactivity, and limiting the aqueous stability of activated esters. For native antibody (Ab) labeling, we show that the small IgG-binding protein GB1 can be covalently attached to the Ab Fc domain...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6k82t8tp</guid>
      <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Liu, Yazhi</name>
      </author>
      <author>
        <name>Nadig, Isha</name>
      </author>
      <author>
        <name>Mehta, Abijeet Singh</name>
      </author>
      <author>
        <name>Chuo, Shih-Wei</name>
      </author>
      <author>
        <name>Ho, Yen H</name>
      </author>
      <author>
        <name>Tyler, James</name>
      </author>
      <author>
        <name>Craik, Charles S</name>
        <uri>https://orcid.org/0000-0001-7704-9185</uri>
      </author>
      <author>
        <name>Anwar, Mekhail</name>
      </author>
      <author>
        <name>Cohen, Bruce E</name>
      </author>
    </item>
    <item>
      <title>Type 2 lymphocytes restrict type 3 lymphocytes during liver fibrosis and colocalize in fibroblast niches.</title>
      <link>https://escholarship.org/uc/item/4k8947vz</link>
      <description>Fibroblasts are dynamic structural cells that direct both beneficial tissue repair and pathological organ fibrosis through interactions with tissue-resident type 2 lymphocytes (T2Ls) and type 3/17 lymphocytes (T3Ls). The cytokines interleukin-13 (IL-13) and IL-17A, produced by T2Ls and T3Ls, respectively, are linked to both tissue inflammation and fibrosis, but how their spatial positioning influences beneficial or pathological organ remodeling remains unclear. Using mouse models of liver injury and fibrosis, three-dimensional microscopy, and spatial transcriptomics, we found an accumulation of periportal and fibrotic tract T2Ls, predominantly group 2 innate lymphoid cells (ILC2s), positioned near T3Ls and niche adventitial fibroblasts and adjacent to discrete profibrotic myofibroblasts. Unexpectedly, T2L ablation worsened both carbon tetrachloride- and bile duct ligation-induced liver fibrosis, accompanied by increased IL-17A&lt;sup&gt;+&lt;/sup&gt; T3Ls, predominantly γδ T cells. In contrast,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4k8947vz</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sbierski-Kind, Julia</name>
      </author>
      <author>
        <name>Cautivo, Kelly M</name>
      </author>
      <author>
        <name>Nilsson, Julia</name>
      </author>
      <author>
        <name>Wagner, Johanna C</name>
      </author>
      <author>
        <name>Dahlgren, Madelene W</name>
      </author>
      <author>
        <name>Crystal, Nathan Ewing</name>
      </author>
      <author>
        <name>McClave, Maria</name>
      </author>
      <author>
        <name>Mroz, Nicholas M</name>
        <uri>https://orcid.org/0000-0002-4781-8518</uri>
      </author>
      <author>
        <name>Ganslmeier, Marlene</name>
      </author>
      <author>
        <name>Lizama, Carlos O</name>
      </author>
      <author>
        <name>Gan, Anna Lu</name>
        <uri>https://orcid.org/0009-0002-5178-7352</uri>
      </author>
      <author>
        <name>Matatia, Peri R</name>
      </author>
      <author>
        <name>Taruselli, Marcela T</name>
      </author>
      <author>
        <name>Chang, Anthony A</name>
      </author>
      <author>
        <name>Caryotakis, Sofia</name>
      </author>
      <author>
        <name>O'Leary, Claire E</name>
      </author>
      <author>
        <name>Kotas, Maya</name>
      </author>
      <author>
        <name>Lee, Jun-Hoe</name>
      </author>
      <author>
        <name>Gu, Taeeun</name>
      </author>
      <author>
        <name>Seo, Hyeewon</name>
      </author>
      <author>
        <name>Kim, Hyun Je</name>
      </author>
      <author>
        <name>Mattis, Aras N</name>
      </author>
      <author>
        <name>Peng, Tien</name>
      </author>
      <author>
        <name>Locksley, Richard M</name>
      </author>
      <author>
        <name>Molofsky, Ari B</name>
        <uri>https://orcid.org/0000-0003-0764-3175</uri>
      </author>
    </item>
    <item>
      <title>Timing and Convergence of Ensemble Activity Govern Auditory Thalamocortical Transmission.</title>
      <link>https://escholarship.org/uc/item/4vb1s321</link>
      <description>Coordinated neuronal activity plays an important role in information processing and transmission in the brain. While ensembles' activity provides a more specific and less noisy version of sensory stimulus information than single neurons, their role in information transmission in the auditory pathway remains unclear. We investigated the effects of ensemble activity in the medial geniculate body (MGB) on the activation of neurons in the primary auditory cortex (A1) in female rats. MGB ensembles synchronized within narrow time windows more effectively induced A1 responses than single neurons or ensembles defined in broader time windows. This was facilitated by the convergence of ensemble inputs onto target neurons. Transmission efficacy was higher for narrow-spiking (NS) A1 neurons compared to broad-spiking (BS) neurons. Cortical UP states in isolation had no discernable effect on the transmission efficacy of thalamic cNEs. These findings highlight neuronal ensembles as focal functional...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4vb1s321</guid>
      <pubDate>Mon, 13 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Hu, Congcong</name>
      </author>
      <author>
        <name>Hasenstaub, Andrea R</name>
      </author>
      <author>
        <name>Schreiner, Christoph E</name>
        <uri>https://orcid.org/0000-0002-4571-4328</uri>
      </author>
    </item>
    <item>
      <title>Auditory cortical forward masking effects in squirrel monkeys with unilateral noise-induced hearing loss</title>
      <link>https://escholarship.org/uc/item/2qj6b8m1</link>
      <description>Forward masking provides a sensitive measure of temporal and spectral processing in the auditory system and reflects underlying inhibitory mechanisms in auditory cortex. The present study examined how unilateral, noise-induced hearing loss (NIHL) alters cortical forward-masking properties in the primary auditory cortex (A1) of squirrel monkeys. Multi-unit responses were recorded from A1 of two control and two NIHL animals six months after right-ear acoustic overstimulation (1 kHz, 136 dB SPL, 3 h). Sequential masker-probe tones were presented with a 10 ms interval while masker frequency was varied around each site's best frequency (BF). In control cortex, probe responses were predominantly suppressed by the preceding masker with strong forward suppression centered near BF. In contrast, NIHL animals exhibited markedly fewer suppressive sites and more facilitatory responses. Suppression strength and inhibitory bandwidth were reduced particularly for low-BF neurons near the 1 kHz...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2qj6b8m1</guid>
      <pubDate>Mon, 13 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cheung, Steven W</name>
      </author>
      <author>
        <name>Schreiner, Christoph E</name>
        <uri>https://orcid.org/0000-0002-4571-4328</uri>
      </author>
    </item>
    <item>
      <title>Perceived benefits of community-based TB preventive treatment in children in Uganda: When she sees other children getting the same medication, she will feel not alone.</title>
      <link>https://escholarship.org/uc/item/1tj1c9v2</link>
      <description>Tuberculosis preventive treatment (TPT) uptake among children at risk for TB remains low in sub-Saharan Africa. Community-based TPT delivery is effective at increasing uptake and completion in children compared to clinic-based models, but implementation research is needed to inform scale-up in real-world settings. In this qualitative study, we assessed community and health care provider perspectives on the anticipated benefits and barriers of a community-based TPT differentiated delivery model comprising three components: (1) initial screening and TPT initiation at the nearest public health facility; (2) community health worker (CHW)-led TB education with community-based medication delivery; and (3) CHW-facilitated delivery in a Community Adherence Group (CAG). From 5 September to 12 October 2023, we conducted in-depth semi-structured interviews (N = 20) with a purposively selected sample of six public health care providers, four CHWs, and ten caregivers of children with latent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tj1c9v2</guid>
      <pubDate>Mon, 13 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kakande, Elijah</name>
      </author>
      <author>
        <name>Johnson-Peretz, Jason</name>
      </author>
      <author>
        <name>Abbott, Rachel</name>
      </author>
      <author>
        <name>Ssekyanzi, Bob</name>
      </author>
      <author>
        <name>Twinomujuni, Maxim</name>
      </author>
      <author>
        <name>Atwiine, Fred</name>
      </author>
      <author>
        <name>Korukiiko, Milliam</name>
      </author>
      <author>
        <name>Atuhaire, Hellen</name>
      </author>
      <author>
        <name>Nangendo, Joan</name>
      </author>
      <author>
        <name>Nattabi, Gloria</name>
      </author>
      <author>
        <name>Ariho, Willington</name>
      </author>
      <author>
        <name>Lavoy, Geoff</name>
      </author>
      <author>
        <name>Chamie, Gabriel</name>
      </author>
      <author>
        <name>Balzer, Laura</name>
      </author>
      <author>
        <name>Havlir, Diane</name>
      </author>
      <author>
        <name>Semitala, Fred</name>
      </author>
      <author>
        <name>Charlebois, Edwin</name>
      </author>
      <author>
        <name>Kamya, Moses</name>
      </author>
      <author>
        <name>Marquez, Carina</name>
      </author>
    </item>
    <item>
      <title>Prioritizing cervical cancer screening services during the COVID-19 pandemic: Response of an academic medical center and a public safety net hospital in California</title>
      <link>https://escholarship.org/uc/item/9vt1d9nx</link>
      <description>The expeditious diagnosis and treatment of high-grade cervical precancers are fundamental to cervical cancer prevention. However, during the COVID-19 pandemic healthcare systems have at times restricted in-person visits to those deemed urgent. Professional societies provided some guidance to clinicians regarding ways in which traditional cervical cancer screening might be modified, but many gaps remained. To address these gaps, leaders of screening programs at an academic medical center and an urban safety net hospital in California formed a rapid-action committee to provide guidance to its practitioners. Patients were divided into 6 categories corresponding to various stages in the screening process and ranked by risk of underlying high-grade cervical precancer and cancer. Tiers corresponding to the intensity of the local pandemic were constructed, and clinical delays were lengthened for the lowest-risk patients as tiers escalated. The final product was a management grid designed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9vt1d9nx</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sawaya, George F</name>
      </author>
      <author>
        <name>Holt, Hunter K</name>
      </author>
      <author>
        <name>Lamar, Robyn</name>
      </author>
      <author>
        <name>Perron-Burdick, Misa</name>
      </author>
      <author>
        <name>Smith-McCune, Karen</name>
      </author>
    </item>
    <item>
      <title>Reply to “Impact of COVID-19 on the mental health of radiologists”</title>
      <link>https://escholarship.org/uc/item/9bp3p17k</link>
      <description>Reply to “Impact of COVID-19 on the mental health of radiologists”</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9bp3p17k</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Cen, Steven Y</name>
      </author>
      <author>
        <name>Lei, Xiaomeng</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Coronavirus Disease 2019 (COVID-19): A Modeling Study of Factors Driving Variation in Case Fatality Rate by Country</title>
      <link>https://escholarship.org/uc/item/85h0d92g</link>
      <description>&lt;i&gt;Background:&lt;/i&gt; The novel Severe Acute Respiratory Syndrome Coronavirus-2 has led to a global pandemic in which case fatality rate (CFR) has varied from country to country. This study aims to identify factors that may explain the variation in CFR across countries. &lt;i&gt;Methods:&lt;/i&gt; We identified 24 potential risk factors affecting CFR. For all countries with over 5000 reported COVID-19 cases, we used country-specific datasets from the WHO, the OECD, and the United Nations to quantify each of these factors. We examined univariable relationships of each variable with CFR, as well as correlations among predictors and potential interaction terms. Our final multivariable negative binomial model included univariable predictors of significance and all significant interaction terms. &lt;i&gt;Results:&lt;/i&gt; Across the 39 countries under consideration, our model shows COVID-19 case fatality rate was best predicted by time to implementation of social distancing measures, hospital beds per 1000...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/85h0d92g</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pan, Jennifer</name>
      </author>
      <author>
        <name>St. Pierre, Joseph Marie</name>
      </author>
      <author>
        <name>Pickering, Trevor A</name>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Desai, Bhushan</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Supporting Diagnosis With Next-Generation Artificial Intelligence—Reply</title>
      <link>https://escholarship.org/uc/item/7nj548sh</link>
      <description>Supporting Diagnosis With Next-Generation Artificial Intelligence—Reply</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7nj548sh</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Adler-Milstein, Julia</name>
      </author>
      <author>
        <name>Chen, Jonathan</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
    </item>
    <item>
      <title>Adhesive capsulitis: review of imaging findings, pathophysiology, clinical presentation, and treatment options</title>
      <link>https://escholarship.org/uc/item/7g7036qj</link>
      <description>Adhesive capsulitis, commonly referred to as “frozen shoulder,” is a debilitating condition characterized by progressive pain and limited range of motion about the glenohumeral joint. It is a condition that typically affects middle-aged women, with some evidence for an association with endocrinological, rheumatological, and autoimmune disease states. Management tends to be conservative, as most cases resolve spontaneously, although a subset of patients progress to permanent disability. Conventional arthrographic findings include decreased capsular distension and volume of the axillary recess when compared with the normal glenohumeral joint, in spite of the fact that fluoroscopic visualization alone is rarely carried out today in favor of magnetic resonance imaging (MRI). MRI and MR arthrography (MRA) have, in recent years, allowed for the visualization of several characteristic signs seen with this condition, including thickening of the coracohumeral ligament, axillary pouch and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7g7036qj</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Skalski, Matthew R</name>
      </author>
      <author>
        <name>Patel, Dakshesh B</name>
      </author>
      <author>
        <name>White, Eric A</name>
      </author>
      <author>
        <name>Tomasian, Anderanik</name>
      </author>
      <author>
        <name>Gross, Jordan S</name>
      </author>
      <author>
        <name>Matcuk, George R</name>
      </author>
    </item>
    <item>
      <title>Saving Academic Radiology: Summary of the 2025 ACR Intersociety Meeting</title>
      <link>https://escholarship.org/uc/item/705788xq</link>
      <description>The American College of Radiology 2025 Intersociety Summer Conference was designed around the theme "The Degradation of the Academic Mission and the Impact on US Radiology". The proceedings have been summarized and analyzed herein, describing the forces that have been undermining the academic mission, examining the short- and long-term impacts of the degradation of academic work on US radiology, and discussing strategies and tactics to maintain the quality of the academic mission and workforce in the face of these challenges.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/705788xq</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Parikh, Jay R</name>
      </author>
      <author>
        <name>Schwartz, Erin S</name>
      </author>
      <author>
        <name>Pang, Laeton J</name>
      </author>
      <author>
        <name>Forster, Bruce B</name>
      </author>
      <author>
        <name>Tuite, Michael J</name>
      </author>
      <author>
        <name>Kattapuram, Taj M</name>
      </author>
      <author>
        <name>Loving, Vilert A</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Vlahos, Ioannis</name>
      </author>
      <author>
        <name>Morgan, Desiree E</name>
      </author>
      <author>
        <name>Wiggins, Ernest F</name>
      </author>
      <author>
        <name>Klein, Katherine</name>
      </author>
      <author>
        <name>Chan, Stephen</name>
      </author>
      <author>
        <name>Gabriel, Helena</name>
      </author>
      <author>
        <name>Heilbrun, Marta</name>
      </author>
      <author>
        <name>Lexa, Frank J</name>
      </author>
    </item>
    <item>
      <title>CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma</title>
      <link>https://escholarship.org/uc/item/6st8m3sw</link>
      <description>Abstract
ObjectivesTo evaluate the utility of&amp;nbsp;CT-based radiomics signatures in discriminating low-grade (grades 1–2) clear cell renal cell carcinomas (ccRCC) from high-grade (grades 3–4) and low TNM stage (stages I–II) ccRCC from high TNM stage (stages III–IV).MethodsA total of 587 subjects (mean age 60.2&amp;nbsp;years ± 12.2; range 22–88.7&amp;nbsp;years) with ccRCC were included. A total of 255 tumors were high grade and 153 were high stage. For each subject, one dominant tumor was delineated as the region of interest (ROI). Our institutional radiomics pipeline was then used to extract&amp;nbsp;2824 radiomics features across 12 texture families from the&amp;nbsp;manually segmented volumes of interest. Separate iterations of the machine learning models using all extracted features (full model) as well as only a subset of previously identified robust metrics (robust model) were developed. Variable of importance (VOI) analysis was performed using the out-of-bag Gini index to identify the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6st8m3sw</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Varghese, Bino A</name>
      </author>
      <author>
        <name>Cen, Steven Y</name>
      </author>
      <author>
        <name>Hwang, Darryl H</name>
      </author>
      <author>
        <name>Aron, Manju</name>
      </author>
      <author>
        <name>Siddiqui, Imran</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Lei, Xiaomeng</name>
      </author>
      <author>
        <name>Yap, Felix Y</name>
      </author>
      <author>
        <name>Rivas, Marielena</name>
      </author>
      <author>
        <name>Reddy, Sharath S</name>
      </author>
      <author>
        <name>Zahoor, Haris</name>
      </author>
      <author>
        <name>Liu, Derek H</name>
      </author>
      <author>
        <name>Desai, Mihir</name>
      </author>
      <author>
        <name>Rhie, Suhn K</name>
      </author>
      <author>
        <name>Gill, Inderbir S</name>
      </author>
      <author>
        <name>Duddalwar, Vinay</name>
      </author>
    </item>
    <item>
      <title>Multimodal spatial transcriptomics reveal the developing human liver niche at single-cell resolution</title>
      <link>https://escholarship.org/uc/item/6rv6j65q</link>
      <description>Background and Aims A comprehensive understanding of the liver niche during development provides insight into a unique, naturally occurring multifunctional multicellular environment. We applied spatial transcriptomic and histologic approaches to identify and histologically validate RNA-based markers in human liver tissue during a critical developmental window when the liver serves as the primary site of hematopoiesis, just prior to the rapid growth phase of the third trimester. During this period, the developmental liver niche uniquely supports the coexistence of endodermal- and mesenchymal-derived cell populations that coordinate hematopoietic development and hepatocyte function. Methods Nine formalin-fixed, paraffin-embedded human developmental liver samples underwent histologic processing, staining, and evaluation prior to single-cell–resolution spatial molecular imaging. Spatial transcriptomic profiling was followed by single-cell transcriptomic analysis and validation using...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6rv6j65q</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bailey, Michael</name>
      </author>
      <author>
        <name>Leon, Michael</name>
      </author>
      <author>
        <name>Rosso, Isabella</name>
      </author>
      <author>
        <name>Sangokoya, Carolyn</name>
      </author>
    </item>
    <item>
      <title>Sleep quality and disturbance during the COVID-19 pandemic among people with HIV globally: associations with social determinants of health.</title>
      <link>https://escholarship.org/uc/item/6qw593g4</link>
      <description>OBJECTIVE: To examine the impact of COVID-19 on sleep quality and sleep disturbance and explore the relationship between social determinants of health, clinical factors, and sleep quality and sleep disturbance in a global sample of people with HIV (PWH).
DESIGN: Cross-sectional prospective international observational study to examine the social, mental, and physical health impacts of COVID-19 on sleep health of PWH.
METHODS: A modified version of the Adolescent Trials Network (ATN) COVID Questionnaire was utilized to collect sleep quality and social determinant of health data in adult PWH. Sleep disturbance was determined from a single item from the Fear of COVID-19 Scale. A series of logistic regressions were conducted to explore the relationship of social determinants of health with decreased sleep quality and disturbance.
RESULTS: A sample of 1,601 PWH from four continents (Africa, Asia, North America, and South America) were included with 61% male, a mean age of 44.18 (±13.67)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6qw593g4</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Davey, Christine Horvat</name>
      </author>
      <author>
        <name>Dawson-Rose, Carol S</name>
        <uri>https://orcid.org/0000-0001-6066-1853</uri>
      </author>
      <author>
        <name>Nokes, Kathleen M</name>
      </author>
      <author>
        <name>Corless, Inge B</name>
      </author>
      <author>
        <name>Shaibu, Sheila</name>
      </author>
      <author>
        <name>Chen, Wei-Ti</name>
      </author>
      <author>
        <name>Maria, Diane Santa</name>
      </author>
      <author>
        <name>Schnall, Rebecca</name>
      </author>
      <author>
        <name>Apiruknapanond, Panta</name>
      </author>
      <author>
        <name>Wang, Tongyao</name>
      </author>
      <author>
        <name>Valencia-Molina, Claudia P</name>
      </author>
      <author>
        <name>Solís-Báez, Solymar</name>
      </author>
      <author>
        <name>Iwu, Emilia</name>
      </author>
      <author>
        <name>Lekone, Lefitile</name>
      </author>
      <author>
        <name>Makhado, Lufuno</name>
      </author>
      <author>
        <name>Cuca, Yvette P</name>
        <uri>https://orcid.org/0000-0002-5674-4741</uri>
      </author>
      <author>
        <name>Phillips, J Craig</name>
      </author>
    </item>
    <item>
      <title>Correction to: Non-invasive prenatal testing of beta-hemoglobinopathies using next generation sequencing, in-silico sequence size selection, and haplotyping.</title>
      <link>https://escholarship.org/uc/item/6pw7w0mg</link>
      <description>This corrects the article DOI:10.3325/cmj.2024.65.180.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6pw7w0mg</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Erlich, Henry A</name>
      </author>
      <author>
        <name>Ko, Lily</name>
      </author>
      <author>
        <name>Lee, Jiyae</name>
      </author>
      <author>
        <name>Eaton, Katrina</name>
      </author>
      <author>
        <name>Calloway, Cassandra D</name>
      </author>
      <author>
        <name>Lal, Ashutosh</name>
      </author>
      <author>
        <name>Das, Reena</name>
      </author>
      <author>
        <name>Jamwal, Manu</name>
      </author>
      <author>
        <name>Lopez-Pena, Christian</name>
      </author>
      <author>
        <name>Mack, Steven J</name>
        <uri>https://orcid.org/0000-0001-9820-9547</uri>
      </author>
    </item>
    <item>
      <title>IDENTIFYING THE AGGRESSION IMPULSIVE/REACTIVE (AIR) PROFILE IN YOUTH WITH BEHAVIORAL CHALLENGES: LATENT PROFILE ANALYSIS IN REAL-WORLD CLINICAL DATA</title>
      <link>https://escholarship.org/uc/item/6jz8r6b8</link>
      <description>IDENTIFYING THE AGGRESSION IMPULSIVE/REACTIVE (AIR) PROFILE IN YOUTH WITH BEHAVIORAL CHALLENGES: LATENT PROFILE ANALYSIS IN REAL-WORLD CLINICAL DATA</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6jz8r6b8</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Langfus, Joshua</name>
      </author>
      <author>
        <name>Youngstrom, Eric</name>
      </author>
      <author>
        <name>Stepanova, Ekaterina</name>
      </author>
      <author>
        <name>Findling, Robert</name>
      </author>
    </item>
    <item>
      <title>P2.04B.13 Time to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials</title>
      <link>https://escholarship.org/uc/item/6dg2d373</link>
      <description>P2.04B.13 Time to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6dg2d373</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kim, E</name>
      </author>
      <author>
        <name>Cenzer, I</name>
      </author>
      <author>
        <name>Graham, FJ</name>
      </author>
      <author>
        <name>Kang, J</name>
      </author>
      <author>
        <name>Lee, S</name>
      </author>
      <author>
        <name>Rustagi, AS</name>
        <uri>https://orcid.org/0000-0003-4880-7658</uri>
      </author>
    </item>
    <item>
      <title>Managing Minimally Abnormal Cervical Cancer Screening Test Results</title>
      <link>https://escholarship.org/uc/item/6bb0x1tn</link>
      <description>This JAMA Insights review summarizes 2020 consensus guidelines on management of minimally abnormal cervical cancer screening results, including no abnormal pathology, atypical squamous cells of undetermined significance (ASCUS), and low-grade squamous intraepithelial lesion (LSIL) with and without positive high-risk HPV testing.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6bb0x1tn</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sawaya, George F</name>
      </author>
      <author>
        <name>Lamar, Robyn</name>
      </author>
      <author>
        <name>Perkins, Rebecca B</name>
      </author>
    </item>
    <item>
      <title>Monitoring After Treatment of Precancerous Cervical Lesions</title>
      <link>https://escholarship.org/uc/item/65m7b80w</link>
      <description>This Clinical Insights provides a comprehensive overview of monitoring patients after treatment of precancerous cervical lesions.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/65m7b80w</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sawaya, George F</name>
      </author>
      <author>
        <name>Lareau, Bennett</name>
      </author>
      <author>
        <name>Lamar, Robyn</name>
      </author>
    </item>
    <item>
      <title>Quantitative magnetic resonance imaging (q-MRI) for the assessment of soft-tissue sarcoma treatment response: a narrative case review of technique development</title>
      <link>https://escholarship.org/uc/item/6442k55x</link>
      <description>Soft-tissue sarcomas are a heterogeneous class of tumors that exhibit varying degrees of cellularity and cystic degeneration in response to neoadjuvant chemotherapy. This creates unique challenges in the radiographic assessment of treatment response when relying on conventional markers such as tumor diameter (RECIST criteria). In this case series, we provide a narrative discussion of technique development for whole tumor volume quantitative magnetic resonance imaging (q-MRI), highlighting cases from a small pilot study of 8 patients (9 tumors) pre- and post-neoadjuvant chemotherapy. One of the methods of q-MRI analysis (the "constant-cutoff" technique) was able to predict responders versus non-responders based on percent necrosis and viable tumor volume calculations (p&amp;nbsp;=&amp;nbsp;0.05), respectively. Our results suggest that q-MRI of whole tumor volume contrast enhancement may have a role in tumor response assessment, although further validation is needed.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6442k55x</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Hwang, Darryl</name>
      </author>
      <author>
        <name>Cen, Steven</name>
      </author>
      <author>
        <name>Desai, Bhushan</name>
      </author>
      <author>
        <name>Gulati, Mittul</name>
      </author>
      <author>
        <name>Hu, James</name>
      </author>
      <author>
        <name>Duddalwar, Vinay</name>
      </author>
      <author>
        <name>Varghese, Bino</name>
      </author>
      <author>
        <name>Matcuk, George R</name>
      </author>
    </item>
    <item>
      <title>Impacts of the Coronavirus Disease 2019 (COVID-19) pandemic on healthcare workers: A nationwide survey of United States radiologists</title>
      <link>https://escholarship.org/uc/item/6115n2zz</link>
      <description>BACKGROUND: Efforts to reduce nosocomial spread of COVID-19 have resulted in unprecedented disruptions in clinical workflows and numerous unexpected stressors for imaging departments across the country. Our purpose was to more precisely evaluate these impacts on radiologists through a nationwide survey.
METHODS: A 43-item anonymous questionnaire was adapted from the AO Spine Foundation's survey and distributed to 1521 unique email addresses using REDCap™&amp;nbsp;(Research Electronic Data Capture). Additional invitations were sent out to American Society of Emergency Radiology (ASER) and Association of University Radiologists (AUR) members. Responses were collected over a period of 8&amp;nbsp;days. Descriptive analyses and multivariate modeling were performed using SAS v9.4 software.
RESULTS: A total of 689 responses from radiologists across 44 different states met the criteria for inclusion in the analysis. As many as 61% of respondents rated their level of anxiety with regard to COVID-19...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6115n2zz</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Song, Catherine</name>
      </author>
      <author>
        <name>Reddy, Sravanthi</name>
      </author>
      <author>
        <name>Desai, Bhushan</name>
      </author>
      <author>
        <name>Cen, Steven Y</name>
      </author>
      <author>
        <name>Salehi, Sana</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Curriculum Innovation</title>
      <link>https://escholarship.org/uc/item/5hz7f0tz</link>
      <description>Background and Objectives: While academic centers have traditionally valued faculty research and educational accomplishments, clinical excellence is often assumed or underappreciated. Accordingly, neurology residency programs frequently offer structured pathways for aspiring clinician-scientists or educators, but few offer dedicated training to launch residents into academic careers focused on clinical mastery. Guided by self-regulated learning principles and the Master Adaptive Learner framework, the aim of this curriculum was to equip neurology postgraduate year (PGY)-4 residents with the foundational skills of the master clinician by advancing the following: (1) clinical acumen and diagnostic reasoning; (2) a scholarly and evidence-informed approach to their work; (3) outstanding communication, professionalism, and humanism; and (4) effective navigation and leadership within complex health care systems.
Methods: Using the Kern six-step curriculum design framework, we developed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5hz7f0tz</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Richie, Megan</name>
      </author>
      <author>
        <name>Douglas, Vanja C</name>
      </author>
      <author>
        <name>Josephson, S Andrew</name>
      </author>
      <author>
        <name>Dhaliwal, Gurpreet</name>
      </author>
    </item>
    <item>
      <title>Whole-tumor 3D volumetric MRI-based radiomics approach for distinguishing between benign and malignant soft tissue tumors</title>
      <link>https://escholarship.org/uc/item/5gx6z1p6</link>
      <description>ObjectivesOur purpose was to differentiate between malignant from benign soft tissue neoplasms using a combination of MRI-based radiomics metrics and machine learning.MethodsOur retrospective study identified 128 histologically diagnosed benign (n = 36) and malignant (n = 92) soft tissue lesions. 3D ROIs were manually drawn on 1 sequence of interest and co-registered to other sequences obtained during the same study. One thousand seven hundred eight radiomics features were extracted from each ROI. Univariate analyses with supportive ROC analyses were conducted to evaluate the discriminative power of predictive models constructed using Real Adaptive Boosting (Adaboost) and Random Forest (RF) machine learning approaches.ResultsUnivariate analyses demonstrated that 36.89% of individual radiomics varied significantly between benign and malignant lesions at the p ≤ 0.05 level. Adaboost and RF performed similarly well, with AUCs of 0.77 (95% CI 0.68–0.85) and 0.72 (95% CI 0.63–0.81),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5gx6z1p6</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Hwang, Darryl H</name>
      </author>
      <author>
        <name>Varghese, Bino A</name>
      </author>
      <author>
        <name>Cen, Steven Y</name>
      </author>
      <author>
        <name>Lei, Xiaomeng</name>
      </author>
      <author>
        <name>Desai, Bhushan</name>
      </author>
      <author>
        <name>Duddalwar, Vinay</name>
      </author>
      <author>
        <name>Matcuk, George R</name>
      </author>
    </item>
    <item>
      <title>Coronavirus Disease 2019 (COVID-19) diagnostic technologies: A country-based retrospective analysis of screening and containment procedures during the first wave of the pandemic</title>
      <link>https://escholarship.org/uc/item/54v7s2x5</link>
      <description>Since first report of a novel coronavirus in December of 2019, the Coronavirus Disease 2019 (COVID-19) pandemic has crippled healthcare systems around the world. While many initial screening protocols centered around laboratory detection of the virus, early testing assays were thought to be poorly sensitive in comparison to chest computed tomography, especially in asymptomatic disease. Coupled with shortages of reverse transcription polymerase chain reaction (RT-PCR) testing kits in many parts of the world, these regions instead turned to the use of advanced imaging as a first-line screening modality. However, in contrast to previous Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome coronavirus epidemics, chest X-ray has not demonstrated optimal sensitivity to be of much utility in first-line screening protocols. Though current national and international guidelines recommend for the use of RT-PCR as the primary screening tool for suspected cases of COVID-19,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/54v7s2x5</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Gholamrezanezhad, Ali</name>
      </author>
    </item>
    <item>
      <title>Microbial sensing through the non-canonical inflammasome modulates airway type 2 immunity</title>
      <link>https://escholarship.org/uc/item/5139g78t</link>
      <description>Airway epithelial cells serve as critical sensors of both microbes and allergens, orchestrating immune responses through damage-associated molecular patterns including IL-33. Common aeroallergens induce type 2 inflammation through protease activity and pore-forming mechanisms that trigger epithelial IL-33 secretion and MAPK signaling. While microbial pattern receptors such as caspase-4 (which detects intracellular LPS) similarly generate membrane pores via the non-canonical inflammasome, it remains unknown whether these receptors can engage the same downstream epithelial IL-33 release and MAPK activation pathways. Using human airway epithelial cell models, we examined caspase-4-dependent pyroptotic signaling downstream of intracellular LPS, including gasdermin D cleavage, IL-33 release, and MAPK-dependent transcriptional responses. We assessed the modulatory effect of protease allergen co-exposure on LPS-induced pyroptosis and interrogated the role of Orai1-mediated calcium signaling...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5139g78t</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bernard, Olivier</name>
      </author>
      <author>
        <name>Yamato, Sheyla</name>
      </author>
      <author>
        <name>Bello, Oluwaferanmi</name>
      </author>
      <author>
        <name>Alvarez, Raquel</name>
      </author>
      <author>
        <name>Supple, Carter J</name>
      </author>
      <author>
        <name>Sharp, Louis Z</name>
      </author>
      <author>
        <name>Kumar, Jahanvi</name>
      </author>
      <author>
        <name>Kotas, Maya E</name>
      </author>
      <author>
        <name>Gordon, Erin D</name>
        <uri>https://orcid.org/0000-0001-7723-2297</uri>
      </author>
    </item>
    <item>
      <title>Navigating a Radiology Conference: A Comprehensive Guide for Learners</title>
      <link>https://escholarship.org/uc/item/4kz0c493</link>
      <description>Navigating a Radiology Conference: A Comprehensive Guide for Learners</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4kz0c493</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mittal, Anisha</name>
      </author>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Choe, Angela I</name>
      </author>
      <author>
        <name>McGillen, Kathryn</name>
      </author>
    </item>
    <item>
      <title>Primary hepatic angiosarcoma: A case-based discussion of unique presentations and extrahepatic manifestations</title>
      <link>https://escholarship.org/uc/item/4j57r5f8</link>
      <description>Hepatic angiosarcoma is a rare and heterogeneous neoplasm that carries with it an especially poor prognosis. Diagnosis is challenging given that patients often present with vague, nonspecific complaints, and early multiorgan dysfunction has the potential to produce a number of unique clinical syndromes. Here, we present a case of a patient with hepatic angiosarcoma who developed cryptogenic cirrhosis, Kasabach-Merritt Syndrome (consumptive thrombocytopenia), and bone marrow fibrosis as a result of her malignant lesions. While parenchymal biopsy ultimately remains the gold standard for diagnosis, careful review of enhancement patterns on imaging may suggest malignant features in need of further investigation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4j57r5f8</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fields, Brandon KK</name>
        <uri>https://orcid.org/0000-0002-1727-2091</uri>
      </author>
      <author>
        <name>Matcuk, George R</name>
      </author>
      <author>
        <name>Lai, Doan</name>
      </author>
      <author>
        <name>Lee, Andrew</name>
      </author>
      <author>
        <name>Dwabe, Sami</name>
      </author>
      <author>
        <name>Hanlon, Courtney</name>
      </author>
      <author>
        <name>Demirjian, Natalie L</name>
      </author>
      <author>
        <name>Politano, Seth</name>
      </author>
    </item>
    <item>
      <title>Enhanced Prenatal Care Models and Postpartum Depression</title>
      <link>https://escholarship.org/uc/item/4bb511wk</link>
      <description>Racial, ethnic, and income disparities in perinatal depression prevalence and treatment are partially driven by social determinants of health. Effective treatments addressing these determinants are needed. To determine whether enhanced group prenatal care (eGPC) outperforms enhanced individual prenatal care (eIPC) for reducing perinatal depressive symptoms. This randomized clinical trial was conduced in 10 Medicaid-serving clinics in California’s San Joaquin Valley, enrolling English- or Spanish-speaking Medicaid-eligible pregnant individuals at less than 25 weeks’ gestation, from November 2019 to January 2024, with 2 follow-up surveys through 12 weeks postpartum. Analyses were conducted as intention-to-treat. Data were analyzed from December 2024 to December 2025. Participants were randomized to eIPC or eGPC. eIPC enhancements included assessments tailored to individual psychosocial, clinical, oral health, and substance use needs. eGPC enhancements included childcare, perinatal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4bb511wk</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Felder, Jennifer N</name>
      </author>
      <author>
        <name>León-Martínez, Daisy</name>
      </author>
      <author>
        <name>Karasek, Deborah</name>
      </author>
      <author>
        <name>Curry, Venise</name>
      </author>
      <author>
        <name>Carraway, Kristin</name>
      </author>
      <author>
        <name>Afulani, Patience A</name>
      </author>
      <author>
        <name>Blebu, Bridgette</name>
      </author>
      <author>
        <name>Chambers-Butcher, Brittany</name>
      </author>
      <author>
        <name>Coleman-Phox, Kimberly</name>
      </author>
      <author>
        <name>Simard, Bethany J</name>
      </author>
      <author>
        <name>Blat, Cinthia</name>
      </author>
      <author>
        <name>Garza, Mary A</name>
      </author>
      <author>
        <name>McCulloch, Charles E</name>
      </author>
      <author>
        <name>Kuppermann, Miriam</name>
        <uri>https://orcid.org/0000-0002-8074-6923</uri>
      </author>
    </item>
    <item>
      <title>Mental Health and ART Adherence in a Multisite International Study: The Mediating Roles of Social Support and Substance Use in People with HIV (jan, 10.1007/s10461-025-04944-z, 2026)</title>
      <link>https://escholarship.org/uc/item/31b1z39h</link>
      <description>Mental Health and ART Adherence in a Multisite International Study: The Mediating Roles of Social Support and Substance Use in People with HIV (jan, 10.1007/s10461-025-04944-z, 2026)</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/31b1z39h</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Awad, Joseph</name>
      </author>
      <author>
        <name>Sun, Wenxiu</name>
      </author>
      <author>
        <name>Maria, Diane Santa</name>
      </author>
      <author>
        <name>Schnall, Rebecca</name>
      </author>
      <author>
        <name>Apiruknapanond, Panta</name>
      </author>
      <author>
        <name>Wang, Tongyao</name>
      </author>
      <author>
        <name>Valencia, Claudia Patricia</name>
      </author>
      <author>
        <name>Davey, Christine Horvat</name>
      </author>
      <author>
        <name>Baez, Solymar Solis</name>
      </author>
      <author>
        <name>Iwu, Emilia</name>
      </author>
      <author>
        <name>Sabone, Motshedisi</name>
      </author>
      <author>
        <name>Makhado, Lufuno</name>
      </author>
      <author>
        <name>Cuca, Yvette P</name>
        <uri>https://orcid.org/0000-0002-5674-4741</uri>
      </author>
      <author>
        <name>Phillips, J Craig</name>
      </author>
      <author>
        <name>Corless, Inge B</name>
      </author>
      <author>
        <name>Shaibu, Sheila</name>
      </author>
      <author>
        <name>Dawson-Rose, Carol</name>
      </author>
      <author>
        <name>Chen, Wei-Ti</name>
      </author>
    </item>
    <item>
      <title>Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials</title>
      <link>https://escholarship.org/uc/item/2js9153x</link>
      <description>&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; The Positive and Negative Syndrome Scale (PANSS) is a widely accepted outcome measure for pediatric schizophrenia trials; however, it has notable limitations. Psychometric investigations have shown a multifactorial structure and some items have limited utility assessing symptom severity in children. To address these issues, we developed and evaluated optimized 10- and 20-item PANSS short-forms (PANSS10 and PANSS20) using patient-level clinical trial data. This study further assesses these optimized forms using independent clinical trial data. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We examined patient-level data from a randomized pediatric schizophrenia trial comparing paliperidone ER to aripiprazole. Data were accessed through the Yale Open Data Access (YODA) secure platform. Analyses included confirmatory factor analyses, graded response models, ω score reliability, internal consistency, sensitivity to change, and criterion validity versus the Clinical Global Impressions...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2js9153x</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Langfus, Joshua A</name>
      </author>
      <author>
        <name>Youngstrom, Eric A</name>
      </author>
      <author>
        <name>Daniel, David</name>
      </author>
      <author>
        <name>Busner, Joan</name>
      </author>
      <author>
        <name>Findling, Robert L</name>
      </author>
    </item>
  </channel>
</rss>
